UNITED STATES


SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-K

(Mark One)
 
ýxANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended: December 31, 20092011
 
OR
 
o¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  
For the transition period from                 to                     
 
Commission file number: 0-11668
Photonic Products Group,

Inrad Optics, Inc.

(Exact name of registrant as specified in its charter)

New Jersey 22-2003247
State or other jurisdiction of incorporation or organization (I. R. S. Employer Identification No.)
   
181 Legrand Avenue, Northvale, NJ 07647
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code 201-767-1910

201-767-1910

Securities registered pursuant to Section 12(b) of the Act:None

  Name of each exchange 
Title of each class on which registered 

Securities registered pursuant to section 12(g) of the Act:

Common stock, par value $.01 Per Share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined inRule 405 of the Securities Act. Yeso¨.      No ýx.

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes  o¨.      No ýx.

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

   YesýxNoo¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                                                                                                                      Yesx          No¨

Indicate by check mark if disclosure of delinquent filers pursuant toItem 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference inPart III of this Form 10-K or any amendment to this Form 10-K.o¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated file, or a smaller reporting company. See definition of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b2 of the Exchange Act. (Check one):

Large accelerated filer  o¨
 
Accelerated filer  o¨
 
Non-accelerated filer  o¨
 
Smaller reporting company  ýx

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

   Yeso¨Noýx

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter.   $10,057,576$9,434,493 (For purposes of determining this amount, only directors, executive officers and shareholders with voting power of 10% or more of our stock have been deemed affiliates.)

Note.  If a determination as to whether a particular person or entity is an affiliate cannot be made without involving unreasonable effort and expense, the aggregate market value of the common stock held by non-affiliates may be calculated on the basis of assumptions reasonable under the circumstances, provided that the assumptions are set forth in this Form.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

Common Shares outstanding as of March 29, 2010

11,552,150
2012 - 11,864,124 shares

Documents Incorporated by Reference

Reference: Portions of the registrant's definitive proxy statementProxy Statement for the 2012 Annual Meeting of Shareholders, to be filed with the Commission not later than 120 days after the endclose of the registrant’s fiscal year, covered by this report arehave been incorporated by reference, in whole or in part, into Part III.
III Items 10, 11, 12, 13 and 14 of this Annual Report on 10-K.




Photonic Products Group, Inc.

INDEX

Inrad Optics, Inc.

INDEX

Part I

 
    
Item 1. Business  32
    
Item 1A. Risk Factors7
    
Item 1B. Unresolved Staff Comments98
    
Item 2. Properties  98
    
Item 3. Legal Proceedings9
    
Item 4. ReservedMine Safety Disclosures9
    
Part II
   
    
Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities10
    
Item 6. Selected Financial Data11
    
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation11
    
Item 7A. Quantitative and Qualitative Disclosures about Market Risk  1817
    
Item 8. Financial Statements and Supplementary Data1917
    
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure1917
    
Item 9A Controls and Procedures1917
    
Item 9B Other Information  1918
    
Part III
   
    
Item 10. Directors, Executive Officers and Corporate Governance  2019
    
Item 11. Executive Compensation  2019
    
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters2019
    
Item 13. Certain Relationships and Related Transactions, and Director Independence  2019
    
Item 14. Principal Accounting Fees and Services2019
    
Part IV
   
    
Item 15 Exhibits and Financial Statement Schedules2120
    
Signatures2321

1
2

PART 1

Caution Regarding Forward Looking Statements

This Annual Report contains forward-looking statements as that term is defined in the federal securities laws. The Company wishes to insure that any forward-looking statements are accompanied by meaningful cautionary statements in order to comply with the terms of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. The events described in the forward-looking statements contained in this Annual Report may not occur. Generally, these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of the Company’s plans or strategies, projected or anticipated benefits of acquisitions made by the Company, projections involving anticipated revenues, earnings, or other aspects of the Company’s operating results. The words “may”, “will”, “expect”, “believe”, “anticipate”, “project”, “plan”, “intend”, “estimate”, and “continue”, and their opposites and similar expressions are intended to identify forward-looking statements. The Company cautions you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks, and other influences, many of which are beyond the Company’s control, that may influence the accuracy of the statements and the projections upon which the statements are based. Factors which may affect the Company’s results include, but are not limited to, the risks and uncertainties discussed in Items 1A, 7 and 7A. Any one or more of these uncertainties, risks, and other influences could materially affect the Company’s results of operations and whether forward-looking statements made by the Company ultimately prove to be accurate. Readers are further cautioned that the Company’s financial results can vary from quarter to quarter, and the financial results for any period may not necessarily be indicative of future results. The foregoing is not intended to be an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by the Company. The Company’s actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward looking statements, whether from new information, future events, or otherwise, except as otherwise required by law.

Item 1. Business
Photonic Products Group,
Item 1.Business

Inrad Optics, Inc. (the “Company” or “PPGI”, “Inrad”), was incorporated in New Jersey in 1973,1973. The Company develops, manufactures and markets products and services for use in diverse photonics industry sectors via its multiple business units.

three distinct but complimentary product areas - “Crystals and Devices”, “Custom Optics” and “Metal Optics.”

Prior to September 2003 PPGIthe Company was named and did business solely as Inrad, Inc. Company management,In 2003, the Board of Directors and shareholders approved thea name change in 2003.

to Photonic Products Group, Inc. (PPGI) and then to Inrad Optics, Inc. on January 18, 2012.

In November 2003, the Company purchased the assets and certain liabilities of Laser Optics, Inc. of Bethel, CT. Laser Optics, Inc. was a custom optics and optical coating services provider, in business since 1966. PPGI integrated the Bethel team and their operations into the Company’s Northvale, NJ operations in mid-2004, combining themmid-2004. This integration leveraged Inrad’s original crystalline products with Inrad’sthe custom optics and optical coating product lines under thecapabilities of Laser Optics name.

to provide an enhanced set of product offerings.

In October 2004, the Company acquired MRC Precision Metal Optics, Inc. (“MRC”) of Sarasota, Florida, a precision metal optics and diamond-turned aspheric optics manufacturer, specializing in CNC and single point diamond machining, optical polishing, nickel plating, aluminum, albemetAlBeMet™ and berylliumBeryllium machining.  MRC also provides opto-mechanical assembly services.

PPGI’s

In 2011, the Company undertook a significant review of its brand position within the marketplace and concluded that the Company’s name, “Photonics Products Group, Inc.”, due to its composition of common words within our industry, had not achieved the anticipated level of brand equity since its inception in 2003.  In order to solve this significant business issue, the Company developed and is currently implementing a strategic marketing plan around the brand name of Inrad Optics.  In January 2012, the Company’s shareholders approved a name change to Inrad Optics, Inc.Changing the Company’s name to Inrad Optics, Inc. leverages the positive historical and current brand equity of the Inrad name and more clearly communicates the Company’s principal business activities to both our marketplace and the investment community.

The original “Inrad” name was recognized as one of the photonic industry’s seminal crystalline products fall into two main categories:companies. The Company is now a vertically integrated organization specializing in crystal-based optical components (which include standard and devices, custom optical components from both glass and metal, and precision optical assemblies, single crystals, and opto-mechanical assemblies. Manufacturing capabilities include solution and high temperature crystal components),growth, extensive optical fabrication capabilities, including precision diamond turning and laser system accessories (whichthe ability to handle large substrates, optical coatings and in-process metrology expertise.

Inrad Optics’ customers include wavelength conversion products and Pockel’s cells that use nonlinear crystals for laser wavelength conversion).

The Company is an optical component, subassembly, and sub-system supplier to original equipment manufacturers (“OEM”), research institutes and researchersleading corporations in the defense, aerospace, laser systems, process control and metrology sectors of the photonics industry.
industry, as well as the U.S. Government, National Laboratories and Universities worldwide.

Administrative, engineering and manufacturing operations are in a 42,000 square foot building located in Northvale, New Jersey, about 15 miles northwest of New York City, and in a 25,000 square foot building located in Sarasota, FL. The headquarters of the Company are located in the Northvale facility.

Custom optic manufacturing

The products produced by Inrad Optics, Inc. fall into two main categories: Optical Components and Laser System Devices and Instrumentation.

The Optical Components segment of the business is a major product area for PPGI.heavily focused on custom optics manufacturing. The Company specializes in high-end precision components. It develops, manufactures and delivers precision custom optics and thin film optical coating services through its LaserCustom Optics and MRC business units.  Glass,Metal Optics operations.Glass, metal, and crystal substrates are processed using modern manufacturing equipment, complex processes and techniques to manufacture components, deposit optical thin films, and assemble sub-components used in advanced Photonicphotonic systems. The majority of custom optical components and optical coating services supplied are used in inspection, process control systems, defense and aerospace electro-optical systems, laser system applications, industrial scanners, and medical system applications.

The Company also developsLaser System Devices and manufactures synthetic optical crystals, optical crystal components,Instrumentation category includes the growth and laser accessories through its INRAD business unit.  It grows synthetic crystalsfabrication of crystalline materials with electro-optic (EO), and non-linear and optical properties for use in both its standard and custom products. This category also includes the manufactured crystal based devices and associated instrumentation. The majority of crystals, crystal components and laser accessoriesdevices manufactured are used in laser systems, defense EO systems, medical lasers and R&D applications by engineers within corporations, universities and national laboratories.

3

The following table summarizes the Company’s productnet sales by product categories during the past three years. Laser accessories includeSystem Devices and Instrumentation includes all non-linear and electro-optical crystal components.

  Years Ended December 31, 
  2009  2008  2007 
Category Sales  %  Sales  %  Sales  % 
Optical Components $10,350,000   94  $14,750,000   90  $13,410,000   89 
Laser Accessories  701,000   6   1,551,000   10   1,690,000   11 
TOTAL $11,051,000   100  $16,301,000   100  $15,100,000   100 

  Years Ended December 31, 
  2011  2010  2009 
Category (In thousands) Net Sales  %  Net Sales  %  Net Sales  % 
Optical Components $11,812   90  $10,115   92  $10,350   94 
Laser System Devices and Instrumentation  1,365   10   939   8   701   6 
TOTAL $13,177   100  $11,054   100  $11,051   100 

Products Manufactured by the Company

Optical Components

a)           Custom Optics and Optical Coating Services

a)Custom Optics and Optical Coating Services

Manufacturing of high-performance custom optics is at present a major product area for PPGI,Inrad Optics, Inc. and is addressed in the marketplace throughby each of the three separate brands of INRAD, Laserproduct groups - Crystals and Devices, Custom Optics and MRC.

LaserMetal Optics.

The Custom Optics was formed in 2003 with the combination of INRAD’s custom optics and optical coating services and those of Laser Optics, Inc. which the Company acquired.  The Company had been active in the field since 1973, and Laser Optics, Inc. since 1966.

The Laser Optics business unit produces customproduct linefocuses on products manufactured to its customer’sspecific customer requirements. It specializes in the manufacture of optical components, optical coatings (ultra-violet wavelengths through infra-red wavelengths) and subassemblies for the military, aerospace, industrial and medical marketplace. Planar, prismatic and spherical components are fabricated from glass and synthetic crystals, including fused silica, quartz, infra-red materials (including germanium, zinc selenide, and zinc sulfide),sulfide, magnesium fluoride and silicon. Components consist of mirrors, lenses, prisms, waveplates, polarizing optics, monochrometers, x-ray mirrors, and cavity optics for lasers.

Most optical components and sub-assemblies require thin film coatings on their surfaces. Depending on the design, optical coatings can refract, reflect, or transmit specific wavelengths. LaserThe Custom Optics optical coating specialties include high laser damage resistance, polarizing, highhighly reflective, anti-reflective, infra-red, and coating to complex custom multi-wavelength requirements on a wide range of substrate materials.  Laser Optics coating capability is mainly directed towards optical components it manufactures, as well as customer furnished components. Coating deposition process technologies employed included electron beam, thermal, and ion assist.

MRC

The Metal Optics establishedproduct line is manufactured in 1983,our facility in Sarasota, Florida which is a fully integrated precision metal optics and optical assembly manufacturer.  The Companyoperation which employs high precision CNC and diamond machining, polishing, plating of aluminum, albemet,AlBeMet™, beryllium and stainless steelsteel. The Metal Optics product line offers opto-mechanical design component manufacturing and assembly services in the manufactureas part of custom optics.  MRC has developed custom processes toits manufactured deliverables and can support prototyping through medium to high ratesproduction of  production for large and small metal mirrors, thermally stable optical mirrors, low RMS surface finish polished mirrors, diamond machined precision aspheric and planar mirrors, reflective porro prisms, and arc-second accuracy polygons and motor assemblies. Plating specialties include void-free gold and electrolesselectro-less nickel.

b)           UV Filter Optical Components

b)UV Filter Optical Components

The INRAD crystalsCrystals and crystal componentsDevices product lines include crystallineline includes filter materials includingof both patented and proprietary materials that havewith unique transmission and absorption characteristics that enable them to becharacteristics. These materials are used in critical applications in defense systems such as missile warning sensors. Such materials include nickel sulphate,sulfate, and proprietary materials such as UVC-7 and LAC.

3

Laser Accessories

Devices and Instrumentation

The INRAD business unit manufacturesCrystals and Devices product line consists of crystal-based products that are used in, or alongside, laser systems. Developing growth processes for high quality synthetic crystals is a core competency of the Crystals and Devices manufacturing team. These crystals are embedded in the value added devices and instrumentation products manufactured in our crystal growth production facility and include crystals for wavelength conversion, crystals, Pockel’smodulation and polarization, Pockels cells, and wavelength conversion instruments.

a)           Crystal Components
Certain synthetic crystals, because In addition to the filter materials consumed by the UV Filter Optical components described above, current materials produced include Beta Barium Borate (BBO), Lithium Niobate, Zinc Germanium DiPhosphide, and Potassium Dihydrogen Phosphate and Potassium Dideuterium Phosphate. Applications for these materials include defense, homeland security, surgical lasers, and industrial processing lasers. The Crystals and Devices team is also engaged in ongoing R & D efforts to develop new materials for evolving applications and offers contract growth of their internal structure, have unique optical, non-linear, or electro-optical properties that are essentialcrystalline materials to application in or with laser systems.  Electro-opticcustomer specifications. Some of the major products produced for the photonics marketplace include:

a)Crystal Components

The Company grows and fabricates electro-optic and nonlinear crystal devices can alterfor altering the intensity, polarization or wavelength of a laser beam. Developing growth processes for high quality synthetic crystals and manufacturing and design processes for crystal components lies at the heart of the INRAD laser accessory product lines.  Other crystal components, both standardproduced as part of the Crystals and custom,Devices product line, are used in laser research and in commercial laser systems to change the wavelength of laser light.  Synthetic crystals currently in production include Lithium Niobate, Beta Barium Borate, Alpha Barium Borate, KDP, deuterated KDP Zinc Germanium DiPhosphide, as well as other species.

4

b)           Pockel’s Cells
INRAD manufactures asystems.

b)Pockels Cells

A line of Pockel’s CellsPockels cells and associated electronics.  Pockel’selectronics is manufactured for sale in multiple market sectors. Pockels cells are devices that include one or more crystal components and are used in applications that require fast switching of the polarization direction of a beam of light. These uses include Q-switching of laser cavities to generate pulsed laser light, coupling light into and out from regenerative amplifiers, and light intensity modulation. These devices are sold on an OEM basis to medical and industrial laser original equipment manufacturers, researcher institutes and laser system design engineers.

c)           Harmonic Generation Systems
PPGI’s Inrad business unit

c)Harmonic Generation Systems

The Company designs and manufactures harmonic generation laser accessories.systems and accessories for the laser research R & D community. Harmonic generation systems enable the users of lasers to convert the fundamental frequency of the laser to another frequency required for specific applications. Harmonic generators are used in spectroscopy, semiconductor processing, medical lasers, optical data storage and scientific research.

Many commercial lasers have automatic tuning features, allowing them to produce a range of frequencies. The INRAD AutotrackerCompany’s“Autotracker” product, when used in conjunction with these lasers, automatically generates tunable ultraviolet light or infrared light for use in spectroscopic applications.

Markets

Sales by Market

The photonics industry serves a very broad, fragmented and expanding set of markets. As technologies are discovered, developed and commercialized, the applications for photonic systems and devices, and the components embedded within those devices, grow across traditional market boundaries. While a significant part of the Company’sbusiness remains firmly in the defense and aerospace markets, other markets served include the OEM medical and industrial laser market, and the OEM metrology and process control market, university research institutes and national labs worldwide. Scanning, detection and imaging technologies for homeland security and health care markets are beginning to provide opportunities for Inrad Optics, Inc., and these new sectors are expected toaccount for future growth and demand for Inrad Optics, Inc.’s products and capabilities.

In 2009, 20082011, 2010 and 20072009 the Company’s product sales were made to customers in the following market areas:

Market  (In thousands) 
 2009 
  
 2008 
  2007 
Defense/Aerospace $7,454   (68)% $10,329   (63)% $9,456   (63)%
Process control & metrology  2,339   (21)%  4,692   (29)%  3,760   (25)%
Laser systems (non-military)  138   (1)%  463   (3)%  932   (6)%
Universities & national laboratories  492   (4)%  203   (1)%  352   (2)%
Other  628   (6)%  614   (4)%  600   (4)%
Total $11,051   (100)% $16,301   (100)% $15,100   (100)%
Major market sectors served by the Company include defense

Market  (In thousands) 2011  2010  2009 
Defense/Aerospace $6,734   (51)% $6,968   (63)% $7,454   (68)%
Process control & metrology  4,752   (36)%  2,751   (25)%  2,339   (21)%
Laser systems and other  1,255   (10)%  796   (7)%  766   (7)%
Universities & national laboratories  436   (3)%  539   (5)%  492   (4)%
Total $13,177   (100)% $11,054   (100)% $11,051   (100)%

Defense and aerospace, process control & metrology, laser systems (non-military), universities and national laboratories, and various other markets not separately classified.  The “defense and aerospace”Aerospace

This area consists of sales to OEM defense electro-optical systems and subsystems manufacturers, manufacturers of non-military satellite-based electro-optical systems and subsystems, and direct sales to governments where the products have the same end-use.  The “process control and metrology” area consists of customers who are OEM manufacturers of capital equipment used in manufacturing process implementation and control, optics-based metrology and quality assurance, and inventory and product control equipment.  Examples of

End-use applications for such equipment include semiconductor (i.e., chip) fabrication and testing and inventory management and distribution control.  The “laser systems” market area consists principally of customers who are OEM manufacturers of industrial, medical, and R&D lasers.  “Universities and National Laboratories” consists of product sales to researchers at such institutions.  The “Other” category represents sales to market areas that, while they may be the object of penetration plans by the Company, are not currently large enough to list individually (example: bio-medical), and sales through third parties for whom the end-use sector is not known.

The Company is a provider of optical components, both specialty crystal components and high precision custom optical components for customersInrad Optics’ products in the defense and aerospace and defense electro-optical systems sector.  End-use applicationssector include military laser systems, military electro-optical systems, satellite-based systems, and missile warning sensors and systems that protect aircraft. The dollar volume of shipments of product within this sector depends in large measure on the U.S. Defense Department budget and its priorities, that of foreign governments, the timing of their release of contracts to their prime equipment and systems contractors, and the timing of competitive awards from this customer community to the Company.  The Company’s sales of products to this customer sector increased as a percentage of total sales in 2009, although revenue in this sector fell by almost 28% and 21% from 2008 and 2007, respectively, as the decline in sales in these market areas was less than the decline in sales all other market areas on a percentage basis.  

Defense/aerospaceAerospace sector sales represented approximately 51%, 63% and 68% of sales in 20092011, 2010 and 63%2009. In spite of salesthe decreases in both 20082011 and 2007. The2010, the Company believes that the defense and aerospace sector will continue to represent a significant market for the Company’s products and offers an ongoing opportunity for growth given the Company’s capabilities in specialty crystal, glass and metal precision optics.

Process Control and Metrology

This area consists of customers who are manufacturers of capital equipment used in manufacturing process implementation and control, optics-based metrology and quality assurance, and inventory and product control equipment. Examples of applications for such equipment include semiconductor (i.e., chip) fabrication and testing and inventory management and distribution control.

Sales in the Process Control and Metrology market sector, the Company’s second largest market, decreasedincreased in 20092011, both as a percentage of total sales and in relative sales dollars.dollars, compared to 2010 This reflectedincrease in this sector correlates with the impactrecovery of the economic recession, particularly in the commercial market and within the customer base that the Company serves.  Sales were $2,339,000 or 21% of total sales compared to sales in 2008 of $4,692,000 or 29% of total sales, and sales in 2007 of $3,760,000 or 25% of total sales. Despite the downturn in 2009, thesemi-conductor market. The Company believes that the optical and x-ray inspection segment of the semiconductor industry offers continued opportunities which match its capabilities in precision optics, crystal products, and monochrometers.

5

Laser Systems and Other

This market consists principally of customers who are OEM manufacturers of industrial, medical, and R&D lasers which the Company serves as an OEM supplier of standard and custom optical components and laser accessories, as well as, representing market areas that while they may be the object of penetration plans by the Company, are not currently large enough to list individually. Sales to this market increased in 2011 mainly due to the increased demand for custom components from new customers.

The Company also serves the non-militaryindustrial and medical laser industry as an OEM supplier of standard and custom optical components and laser accessories.  In this sector, 2009

Universities and National Laboratories

These sales were $138,000 or 1%. In 2008,consist of product sales were 463,000 or 3% of total sales compared with sales in 2007 of $932,000 or 6% of total sales.    The sales decline over the last few years primarily reflects the decline in orders from one major customer in this market.

to researchers at various educational and research institutions. Sales to customers within the University and National Laboratories market sector consist primarily of the Company’s legacy systems, Pockel’sPockels cells and related repairs. Although sales for 2011 decreased as a percentage of total sales from 2010, the total dollar amount from sales to this market remained relatively stable over the past three years and is dependent on research projects and the availability of funding for such projects. In 2010, sales increases reflect the availability of stimulus funding for the National Labs following 2009 thewhen sales increased towere $492,000 orand 4% of total sales primarily reflecting a large order from one national laboratory.  This follows a sales decline in 2008 to $203,000 from $352,000 in 2007.
Other sectorsales.

Major Customers

Historically, the Company’s sales have been inconcentrated within a small number of customers, although the $500,000top customers have historically varied from year to $700,000 range historically and growth remained relatively flat at $628,000 in 2009, compared to sales of $614,000 and $600,000 in 2008 and 2007, respectively.

The Company’s export sales, which are primarily to customers in countries within Europe,year. In 2011, the Near East and Japan, amounted to approximately 7.2%, 5.2%, and 9.5% of product sales in 2009, 2008 and 2007, respectively.
The Company had sales to three major domestic customers whichthat accounted for 17.7%20.9%, 15.4% and 13.8%,10.8% of sales. In 2011, the largest account was an international customer that is in the process control and 9.8% of sales in 2009.  Each customer is anmetrology industry. The other two major customers are electro-optical systems divisiondivisions of a major U.S. defense corporationindustry corporations who manufacturesmanufacture systems for U.S. and allied foreign governments. In 2008,2010, the sametop three customers represented 8.7%15.3%, 21.6%10.3% and 5.9%10.1% of sales, respectively.  Sales to these markets are mainly through independent distributors.

During the past three years, sales to the Company’s top five customers represented approximately 51.6%58.1%, 58.8%54.3% and 56.9%55.3% of sales, respectively, in the aggregate.respectively. These top customers have been manufacturesmanufacturers either in the Defensedefense sector or the process control and metrology sector. Given the concentration of sales within a small number of customers, the loss of any of these customers would have a significant negative impact on the Company and its business units.

Export Sales

The Company’s export sales, which are primarily to customers in countries within Europe, Asia and Japan, amounted to approximately 22.8%, 14.9%, and 12.5% of product sales in 2011, 2010 and 2009, respectively.

5

Long-Term Contracts

Certain of the Company’s agreements with customers provide for periodic deliveries at fixed prices over a long period of time. In such cases, as in most other cases as well, the Company attempts to obtain firm price commitments, as well as, cash advances from theseits suppliers for the purchase of the materials necessary to fulfill the order.

Marketing and Business Development

The Company’s two Northvale, NJ-based business units andCompany markets its MRC Optics subsidiary market their products domestically, through theirthe coordinated efforts of the sales, marketing and customer service teams, located in Northvale and Sarasota, respectively, led by the Corporate Vice President–Sales and Marketing.  teams.

The Company has moved towards a strategy of utilizing these combined sales and marketing resources for cross-selling all products, across all business lines.

This strategy is well suited to the diverse and fragmented markets that utilize photonic technologies in multiple form factors.

Independent sales agents are used in countries in major non-U.S. markets, including Canada, UK, EU,the United Kingdom, the European Union, Israel, and Japan.

Trade

Sales and marketing efforts of all product lines and all trade show participation, Internet-basedinternet-based marketing, media and non-media advertising and promotion, and international sales representative and distributor relationships are coordinated at the corporate level under the auspices of the corporate Vice President – Marketing and Sales.

In 2011, the Company undertook a significant marketing effort in the form of a corporate name change and a new branding strategy around the “Inrad Optics” name which was supported by the development of a completely new website and other brand identity marketing efforts.

Backlog

The Company’s order backlog at December 31, 20092011 was $4,359,000,$5,021,000, essentially all of which is expected to be shipped in 2010.2012. The Company’s order backlog as of December 31, 20082010 and 20072009 was $6,102,000$5,047,000 and $9,432,000,$4,359,000, respectively.

Competition

Within each product category in which the Company’s business units are active, there is competition.

Changes in the Photonicsphotonics industry have had an effect on suppliers of custom optics. As end users have introduced products requiring large volumes of optical components, suppliers have responded either by staying small and carving out niche product areas, or by ramping up their own manufacturing capacity and modernizing their manufacturing methods to meet higher volume production rates. ManyAdditionally the availability of an increasingly large variety of inventoried inexpensive catalog optics has led some OEM manufacturers to “design in” these low-cost solutions rather than utilizing custom optics manufacturers lack in-house thin film coating capability.  As a result, there are fewer well-rounded competitors in the custom optics arena,designed and many are equipped with modern facilities and manufacturing methods.  The Company has and continues to judiciously deploy capital towards modernizing its facilities, and has staffed its manufacturing groups with individuals with comprehensive experience in manufacturing management, manufacturing engineering, advanced finishing processes and optical coating processes.  The Company competes on the basis of providing consistently high quality products delivered on time, developing and maintaining strong customer relationships, and continuously improving its capabilities, labor productivity, cost structure, and product cycle times.

manufactured products.

Competition for the Company’s laser accessoriescrystal devices and instrumentation is limited, but competitors’ products are generally lower priced.priced for OEM quantities. The Company’s laser accessoriesdevices are considered to be high quality and generally offer a combination of features not available elsewhere. BecauseAs a result of the Company’s in-house crystal growth capability, this area of the Company’s staffbusiness is knowledgeable about matching appropriate crystalshighly vertically integrated, providing a competitive advantage over other suppliers.

Our metal optics product line has several key competitors who are larger and better equipped to given applications for its laser accessories.

6

compete on high volume work. There are also several large and small competitors who compete with our products on large form factor optics. The Company has made recent inroads within this competitive landscape, and is building brand awareness in the marketplace.

For the crystal product area,products, price, quality, delivery and customer service are market drivers. With advancing globalization, many of the Company’s competitors supplyingwho supply non-linear optical crystals are located overseas, and can offer significantly reduced pricing for some crystal species.  Sales in this arena are declining, but the Company has been able to retain a base by providing the quality and customer service needed by certain OEM customers not readily available from others, and by offering proprietary crystal components for which the Company is either the sole source or one of the few available sources.materials. On many occasions, the quality of the crystal component drives the ultimate performance of the component or instrument into which it is installed. Thus, qualityQuality and technical support are considered to be valuable attributes for a crystal supplier by some, but not all, OEM customers.

Although price is a principal factor in many product categories, competition is also based on product design, product performance, customer confidence, quality, delivery, and customer service.  The Company is a sole-source supplier of products to several major customers who are leaders in their industries. Based on its performance to date, the Company believes that it can continue to compete successfully, in its niches, although no assurances can be given in this regard.

Employees

As of the close of business on March 29, 2010,27, 2012, the Company had 81 full-time employees.

Patents and Licenses

The Company mainly relies on its manufacturing and technological expertise, rather than onknow-how and trade secrets in addition to its patents, to maintain its competitive position in the industry. The Company takes precautionary and protective measures to safeguard its technical design and technical and manufacturing data, and relies onprocesses. The Company executes nondisclosure agreements with its employees to protect its proprietary information.

and customers, where appropriate.

Regulation

Foreign sales of certain of the Company’s products to certain countries may require export licenses from the United States Department of Commerce or Department of State.Commerce. Such licenses are generally available to all but a limited number of countries and are obtained when necessary.required. All requested export licenses of Inrad Optics products have been granted or deemed not-required.

ITAR regulations govern much of the Company’s domestic defense sector business, and the Company sales in 2009, 2008is capable of handling its customers’ technical information under these regulations. Inrad Optics, Inc. is registered with the Directorate of Defense Trade Controls, and 2007 requiring U.S. State Department export approval represented less than 1.0%utilizes a supplier base of total sales.  In all cases, the required export approvals were granted.

similarly registered companies.

There are no other federal regulations or any unusual state regulations that directly affect the sale of the Company’s products other than those environmental compliance regulations that generally affect companies engaged in manufacturing operations in New Jersey and Florida.

Item 1A. Risk Factors
Item 1A.Risk Factors

The Company cautions investors that its performance (and, therefore, any forward looking statement) is subject to risks and uncertainties. Various important factors, including but not limited to the following, may cause the Company’s future results to differ materially from those projected in any forward looking statement.

a)  a)As general economic conditions deteriorate, the Company’s financial results may suffer

Significant economic downturns or recessions in the United States, Europe or Europe, such as the current economic environment in which the Company operates,Asia could adversely affect the Company’s business by causing a temporary or longer term decline in demand for the Company’s goods and services and thus its revenues.  The economic uncertainty has resulted in our key customers delaying orders due to decreased demand by the end users of their products and their difficulty in assessing and projecting end-user needs.

b)The Company has exposure to Government Markets

Sales to customers in the defense industry have increased in the recent past.represent a significant part of our business. These customers in turn generally contract with a governmental entity, typically the U.S. government.government agencies. Most governmental programs are subject to funding approval and can be modified or terminated with no warning upon the determination of a legislative or administrative body. The currentrecent economic crisis is havinghad significant effects on government spending and it is particularly difficult, at this time, to assess how this will continue to impact our defense industry customers and the timing and volume of business we do with them.them, in future periods. The loss or failure to obtain certain contracts or a loss of a major government customer could have a material adverse effect on our business, results of operations or financial condition.

c)  c)The Company’s revenues are concentrated in its largest customer accounts

For the year ended December 31, 2009,2011, five customer accounts represented in the aggregate of approximately 52%58% of total revenues, and three customers individually accounted for 41%more than 10% of revenues. These three customers each represented approximately 18%21%, 14%15% and 10%11% of sales, respectively. Since we are a supplier of custom manufactured components to OEM customers, and have a number of large customers in both the commercial and defense markets the relative size and identity of our largest customer accounts changes somewhat from year to year. In the short term, the loss of any of these large customer accounts or a decline in demand in the sectorsmarkets which they represent could have a material adverse effect on business, our results of operations, and our financial condition.

7

d)  d)The Company depends on, but may not succeed in, developing and acquiring new products and processes

In order to meet the Company’s strategic objectives, the Company needs to continue to develop new processes, to improve existing processes, and to manufacture and market new products. As a result, the Company may continue to make investments in the future in process development and additions to its product portfolio. There can be no assurance that the Company will be able to develop and introduce new products or enhancements to its existing products and processes in a way that achieves market acceptance or other pertinent targeted results. The Company also cannot be sure that it will be successful in acquiring complementary products or technologies or that it will have the human or financial resources to pursue or succeed in such activities.

e)  e)The Company’s business success depends on its ability to recruit and retain key personnel

The Company depends on the expertise, experience, and continuing services of certain scientists, engineers, production and management personnel, and on the Company’s ability to recruit additional personnel. There is competition for the services of these personnel, and there is no assurance that the Company will be able to retain or attract the personnel necessary for its success, despite the Company’s effort to do so. The loss of the services of the Company’s key personnel could have a material adverse affecteffect on its business, on its results of operations, or on its financial condition.

f)  f)The Company may not be able to fully protect its intellectual property

The Company currently holds one material patent applicable to an important product, but does not in general rely on patents to protect its products or manufacturing processes. The Company generally relies on a combination of trade secret and employee non-competition and nondisclosure agreements to protect its intellectual property rights. There can be no assurance that the steps the Company takes will be adequate to prevent misappropriation of the Company’s technology. In addition, there can be no assurance that, in the future, third parties will not assert infringement claims against the Company. Asserting the Company’s rights or defending against third-party claims could involve substantial expense, thus materially and adversely affecting the Company’s business, results of operations or financial condition.

g)  g)Many of the Company’s customer’s industries are cyclical

The Company’s business is significantly dependent on the demand its customers experience for their products. Many of their end users are in industries that historically have experienced a cyclical demand for their products. The industries include but are not limited to, the defense electro-optics industry and the manufacturers of process control capital equipment for the semiconductor tools industry. As a result, demand for the Company’s products are subject to cyclical fluctuations, and this could have a material adverse effect on our business, results of operations, or financial condition.

h)  h)The Company’s manufacturing processes require products from limited sources of supply

The Company utilizes many relatively uncommon materials and compounds to manufacture its products. Examples include optical grade quartz, specialty optical glasses, scarce natural and manmade crystals, beryllium and its alloys, and high purity chemical compounds. The Company’s suppliers could fail to deliver sufficient quantities of these necessary materials on a timely basis, or deliver contaminated or inferior quality materials, or to markedly increase their prices. Any such actions could have an adverse effect on the Company’s business, despite the Company’s efforts to secure long term commitments from its suppliers. Adverse results might include reducing the Company’s ability to meet commitments to its customers, compromising the Company’s relationship with its customers, adversely affecting the Company’s ability to meet expanding demand for its products, or causing the Company’s financial results to deteriorate.

i)The Company faces competition

The Company encounters substantial competition from other companies positioned to serve the same market sectors that the Company serves. Some competitors may have financial, technical, capacity, marketing or other resources more extensive than ours, or may be able to respond more quickly than the Company to new or emerging technologies and other competitive pressures. Some competitors have manufacturing operations in low-cost labor regions such as the Far East and Eastern Europe and can offer products at lower prices than the Company. The Company may not be successful in winning orders against the Company’s present or future competitors, and competition may have a material adverse effect on our business, results of operations or financial condition.

j)The Company’s stock price may fluctuate widely

The Company’s stock is thinly traded. Many factors, including, but not limited to, future announcements concerning the Company, its competitors or customers, as well as quarterly variations in operating results, announcements of technological innovations, seasonal or other variations in anticipated or actual results of operations, changes in earnings estimates by analysts or reports regarding the Company’s industries in the financial press or investment advisory publications, could cause the market price of the Company’s stock to fluctuate substantially. In addition, the Company’s stock price may fluctuate widely for reasons which may be unrelated to operating results. These fluctuations, as well as general economic, political and market conditions such as recessions, military conflicts, or market or market-sector declines, may materially and adversely affect the market price of the Company’s Common Stock. In addition, any information concerning the Company, including projections of future operating results, appearing in investment advisory publications or on-line bulletin boards or otherwise emanating from a source other than the Company could in the future contribute to volatility in the market price of the Company’s Common Stock.

i)  The Company’s manufacturing processes require products from limited sources of supply
The Company utilizes many relatively uncommon materials and compounds to manufacture its products.  Examples include optical grade quartz, specialty optical glasses, scarce natural and manmade crystals, beryllium and its alloys, and high purity chemical compounds.  Failure of the Company’s suppliers to deliver sufficient quantities of these necessary materials on a timely basis, or to deliver contaminated or inferior quality materials, or to markedly increase their prices could have an adverse effect on the Company’s business, despite its efforts to secure long term commitments from the Company’s suppliers.  Adverse results might include reducing the Company’s ability to meet commitments to its customers, compromising the Company’s relationship with its customers, adversely affecting the Company’s ability to meet expanding demand for its products, or causing the Company’s financial results to deteriorate.
j)  The Company faces competition
The Company encounters substantial competition from other companies positioned to serve the same market sectors that the Company serves.  Some competitors may have financial, technical, capacity, marketing or other resources more extensive than ours, or may be able to respond more quickly than the Company to new or emerging technologies and other competitive pressures.  Some competitors have manufacturing operations in low-cost labor regions such as the Far East and Eastern Europe and can offer products at lower price than the Company.  The Company may not be successful in winning orders against the Company’s present or future competitors, and competition may have a material adverse effect on our business, results of operations or financial condition.
8

Item 1B. Unresolved Staff Comments
Item 1B.Unresolved Staff Comments

Not applicable

Item 2. Properties
Item 2.Properties

Administrative, engineering and manufacturing operations are housed in a 42,000 square foot building located in Northvale, New Jersey and in a 25,000 square foot building located in Sarasota, FL.Florida. The headquarters of the Company are in its Northvale facility. On November 1, 2008,2011, the Company signed an extension ofnegotiated a change to the rate on its Northvale lease for two years toand extended the term until October 31, 2010.2013. The Company also has anthe option forof renewing the lease for two additional twoone year, periods, at fixed terms, through October 31, 2012.

Photonic Products Group, Inc’s2014.

The Company’s wholly-owned subsidiary, MRC Precision Metal Optics isInc., (DBA Inrad Optics) has its manufacturing operations in a leased facility located in the Sarasota, FLFlorida pursuant to a net lease expiring on August 31, 2010.  MRC Optics has the option of extending the lease for three additional two year periods through August 31, 2016, at fixed terms.

The2013.

These facilities are adequate to meet current and future projected production requirements.

The total rent for these leases was approximately $519,000, $569,000 and $582,000 $588,000in 2011, 2010 and $570,000 in 2009, 2008 and 2007, respectively. The Company also paid real estate taxes and insurance premiums that totaled approximately $162,000 in 2011, $165,000 in 2010 and $172,000 in 2009, $179,000 in 2008 and $189,000 in 2007.

2009.

Item 3. Legal Proceedings
Item 3.Legal Proceedings

There are no legal proceedings involving the Company as of the date hereof.

Item 4. Reserved
None
9


Item 4.Mine Safety Disclosures

Not Applicable

PART II

Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters
a)           Market Information
Item 5.Market for Registrant’s Common Equity and Related Stockholder Matters

a)Market Information

The Company’s Common Stock, with a par value of $0.01 per share, is traded on the OTC Bulletin Board under the symbol PHPG.

The Company has applied for a new symbol to reflect its new name of Inrad Optics, Inc.

The following table sets forth the range of high and low closing prices for the Company’s Common Stock in each fiscal quarter from the quarter ended March 31, 20082010 through the quarter ended December 31, 2009,2011, as reported by the National Association of Securities Dealers NASDAQ System. Such over-the-counter quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.


  Price 
  High  Low 
       
Quarter ended December 31, 2009 $1.50  $1.00 
         
Quarter ended September 30, 2009  1.50   .96 
         
Quarter ended June 30, 2009  1.90   1.27 
         
Quarter ended March 31, 2009  2.00   1.50 
         
Quarter ended December 31, 2008  2.80   1.40 
         
Quarter ended September 30, 2008  3.25   1.45 
         
Quarter ended June 30, 2008  4.20   2.90 
         
Quarter ended March 31, 2008  4.60   3.51 

  Price 
  High  Low 
       
Quarter ended December 31, 2011 $1.01  $0.95 
         
Quarter ended September 30, 2011  1.03   0.95 
         
Quarter ended June 30, 2011  1.25   0.95 
         
Quarter ended March 31, 2011  1.10   0.90 
         
Quarter ended December 31, 2010  1.05   0.90 
         
Quarter ended September 30, 2010  1.15   0.97 
         
Quarter ended June 30, 2010  1.15   1.00 
         
Quarter ended March 31, 2010  1.35   0.90 

As of March 29, 201027, 2012 the Company’s closing stock price was $1.00$0.95 per share.

b)           Shareholders

b)Shareholders

As of March 15 2010,27, 2012, there were approximately 158145 shareholders of record of our Common Stock. The number of shareholders of record of common stock was approximated based upon the Shareholders’ Listing provided by the Company’s Transfer Agent. As of the same date, the Company estimates that there are an additional 590349 beneficial shareholders.

c)           Dividends
There was no common stock dividend paid in 2009 or 2008.  In 2007, the Company paid an annual dividend of 134,000 shares of Common Stock on its outstanding Series A and Series B convertible preferred stock, valued at the closing price on the dividend date.  The value of the dividend was $238,167.
The Series A convertible preferred stock consisted of 500 shares outstanding at a stated value of $1,000 per share and convertible into common shares at the rate of $1.00 per share was converted into 500,000 common shares of the Company’s stock in April 2007.  A total of 2,032 shares of the Series B convertible preferred stock consisting of 2,082 shares at a stated value of $1,000 per share and convertible into common shares at the rate of $2.50 per share were converted in October and November of 2007.  The remaining 50 shares of Series B preferred stock were redeemed by the Company for a cash payment of $50,000 and an accrued stock dividend of 1,332 common shares.

c)Dividends

The Company has not historically paid cash dividends. Payment of cash dividends is at the discretion of the Company’s Board of Directors and depends, among other factors, upon the earnings, capital requirements, operations and financial condition of the Company. The Company does not anticipate paying cash dividends in the immediate future.

d)           Recent Sales of Unregistered Securities

d)Recent Sales of Unregistered Securities

There were no sales of unregistered securities during 2009.

10

e)           Securities Authorized for Issuance under Equity Compensation Plans

  Number of securities to be issued upon exercise of outstanding options, warrants and rights  Weighted-average price of outstanding options, warrants and rights  Number of securities remaining for future issuance under equity compensation plans 
          
2000 Equity Compensation Program approved by shareholders  1,233,719  $1.12   3,615,177 
             
the fourth quarter of 2011.

e)Securities Authorized for Issuance under Equity Compensation Plans

  Number of securities to
be issued upon exercise
of outstanding options,
warrants and rights
  Weighted-average
exercise price of
outstanding
options, warrants
and rights
  Number of securities
remaining for future issuance
under equity compensation
plans (1)
 
          
2000 Equity Compensation Program approved by shareholders  669,676  $1.05    
             
2010 Equity Compensation Program approved by shareholders  425,000  $0.92   3,590,000 

Item 6. Selected Financial Data
Item 6.Selected Financial Data

The following data is qualified in its entirety by the financial statements presented elsewhere in this Annual Report on Form 10-K.

  As of December 31, or 
  For the Year Ended December 31, 
  2009  2008  2007  2006  2005 
Revenues $11,051,127  $16,301,209  $15,099,878  $13,921,127  $13,785,057 
                     
Net (loss) income  (2,799,992)  1,098,421   1,880,081   772,266   (11,398)
                     
Net (loss) income applicable to common shareholders $(2,799,992) $1,098,421  $1,641,914  $537,766  $(145,398)
                     
Earnings per share                    
Basic (loss) earnings  per share  (0.25)  0.10   0.19   0.07   (0.02)
Diluted (loss) earnings per share  (0.25)  0.08   0.13   0.06   (0.02)
                     
Weighted average shares                    
Basic  11,331,258   10,902,061   8,609,822   7,572,637   7,218,244 
Diluted  11,331,258   15,619,304   13,777,114   11,915,090   7,218,244 
                     
Common stock dividends on Preferred shares        238,167   234,500   134,000 
Total assets  12,610,740   15,732,149   16,077,947   15,316,260   13,481,021 
Long-term obligations  2,844,946   2,853,663   2,990,730   6,299,767   5,963,411 
Shareholders’ equity  7,777,715   10,124,175   7,712,799   5,236,703   3,929,407 

  As of December 31, or 
  For the Year Ended December 31, 
  2011  2010  2009  2008  2007 
                
Revenues $13,177,194  $11,054,178  $11,051,127  $16,301,209  $15,099,878 
                     
Net income (loss)  164,746   (733,813)  (2,799,992)  1,098,421   1.880,081 
                     
Net income (loss) applicable to common shareholders $164,746  $(733,813) $(2,799,992) $1,098,421  $1,641,914 
                     
Earnings per share                    
Basic earnings (loss) per share  0.01   (0.06)  (0.25)  0.10   0.19 
Diluted earnings (loss) per share  0.01   (0.06)  (0.25)  0.08   0.13 
                     
Weighted average shares          ��         
Basic  11,658,891   11,522,297   11,331,258   10,902,061   8,609,822 
Diluted  11,753,669   11,522,297   11,331,258   15,619,304   13,777,114 
                     
Common stock dividends on Preferred shares              238,167 
Total assets  11,838,003   12,621,803   12,610,740   15,732,149   16,077,947 
Long-term obligations (1)  2,825,633   3,960,874   3,819,946   3,678,663   3,665,730 
Shareholders’ equity  7,857,995   7,373,752   7,777,715   10,124,175   7,712,799 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operation

The following discussion and analysis should be read in conjunction with the Company’s consolidated financial statements and the notes thereto presented elsewhere herein. The discussion of results should not be construed to imply any conclusion that such results will necessarily continue in the future.

Critical Accounting Policies

The Company’s significant accounting policespolicies are described in Note 1 of the Consolidated Financial Statements that were prepared in accordance with accounting principles generally accepted in the United States of America. In preparing the Company’s financial statements, the Company made estimates and judgments that affect the results of its operations and the value of assets and liabilities the Company reports. The Company’s actual results may differ from these estimates.

The Company believes that the following summarizes critical accounting policespolicies that require significant judgments and estimates in the preparation of the Company’s consolidated financial statements.

Revenue Recognition

The Company records revenue in accordance with Securitiesfrom the sale of its products and Exchange Commission Staff Accounting Bulletin No. 104, “Revenue Recognition” (“SAB 104”).  Under SAB 104, revenues are recordedservices when all four of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the sales price is fixed or determinable; and collectability is reasonably assured. Losses on contracts are recorded when identified.

11

Inventory

Inventories are stated at the lower of cost (first-in, first-out method) or market. Cost of manufactured goods includes material, labor and overhead.

The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

Goodwill and Intangible assets

Intangible assets with finite lives are amortized on a straight-line basis over the assets’ estimated useful life up to 14 years. The Company periodically evaluates on an annual basis, or more frequently when conditions require, whether events or circumstances have occurred indicating the carrying amount of intangible assets may not be recoverable. When factors indicate that intangible assets should be evaluated for possible impairment, the Company uses an estimate of the associated undiscounted future cash flows compared to the related carrying amount of assets to determine if an impairment loss should be recognized.

Goodwill and intangible assets not subject to amortization are tested in December of each year for impairment, or more frequently if events and circumstances indicate that the assets might have become impaired. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value.

Share-based

Stock-based compensation

Stock based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value of restricted stock units granted is estimated based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

Income Taxes

Deferred income taxes are provided on the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

The Company recognizes the financial statement benefit of an uncertain tax position only after determining that the relevant tax authority would more likely than not sustain the position. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

The Company classifies interest and penalties related to income taxes as income tax expense in its Consolidated Financial Statements

Results of Operations

The following table summarizes the Company’s product sales by product categories during the past three years:


  
Years Ended December 31,
 
  2009  2008  2007 
Category Sales  %  Sales  %  Sales  % 
(In thousands) 
Optical Components $10,350   94  $14,750   90  $13,410   89 
Laser Accessories  701   6   1,551   10   1,690   11 
TOTAL $11,051   100  $16,301   100  $15,100   100 

  Years Ended December 31, 
  2011  2010  2009 
Category Sales  %  Sales  %  Sales  % 
  (In thousands) 
Optical Components $11,812   90  $10,115   92  $10,350   94 
Laser System Devices and Instrumentation  1,365   10   939   8   701   6 
TOTAL $13,177   100  $11,054   100  $11,051   100 

The following table provides information on the Company’s sales to its major business sectors during the past three years:

Market  2009    2008    2007  
       (In thousands)      
Defense/Aerospace $7,454   (68)% $10,329   (63)% $9,456   (63)%
Process control & metrology  2,339   (21)%  4,692   (29)%  3,760   (25)%
Laser systems (non-military)  138   (1)%  463   (3)%  932   (6)%
Universities & national laboratories  492   (4)%  203   (1)%  352   (2)%
Other  628   (6)%  614   (4)%  600   (4)%
Total $11,051   (100)% $16,301   (100)% $15,100   (100)%
12

Market 2011  2010  2009 
  (In thousands) 
Defense/Aerospace $6,734   (51)% $6,968   (63)% $7,454   (68)%
Process control & metrology  4,752   (36)%  2,751   (25)%  2,339   (21)%
Laser systems and other  1,255   (10)%  796   (7)%  766   (7)%
Universities & national laboratories  436   (3)%  539   (5)%  492   (4)%
Total $13,177   (100)% $11,054   (100)% $11,051   (100)%

The following table sets forth, for the past three years, the percentage relationship of statement of operations categories to total revenues.


  Years ended December 31, 
  2009  2008  2007 
Revenues:         
Product sales  100.0%  100.0%  100.0%
Costs and expenses:            
Cost of goods sold  80.5%  70.5%  60.5%
Gross profit margin  19.5%  29.5%  39.5%
Selling, general and administrative expenses  29.7%  23.7%  23.6%
Goodwill impairment charge  14.1%  %  %
(Loss) income from operations  (24.3) %  5.9%  15.9%
Net (loss) income  (25.3) %  6.7%  12.5%

  Years ended December 31, 
  2011  2010  2009 
Revenues:            
Product sales  100.0%  100.0%  100.0%
Costs and expenses:            
Cost of goods sold  73.0%  77.3%  80.5%
Gross profit margin  27.0%  22.7%  19.5%
Selling, general and administrative expenses  24.7%  28.1%  29.7%
Goodwill impairment charge        14.1%
Income (loss) from operations  2.3%  (5.4)%  (24.3)%
Net income (loss)  1.3%  (6.6)%  (25.3)%

Revenues

Total revenues were $13,177,000 in 2011, $11,054,000 in 2010 and $11,051,000 in 2009 $16,301,000 in 2008 and $15,100,000 in 2007 reflecting the consolidated results from all three business units.operations. Revenues decreased 32% in 20092011 increased 19.2% compared with increasesto 2010, which follows two years for relatively unchanged revenues for 2010 and 2009. The increase in 2011 is mainly due to an increase in orders from both new and existing customers in the process control and metrology markets that we serve which was partially offset by a decrease in sales to customers we serve in the defense/aerospace customers. The net increase in revenues in 2011 is comprised of 8%an increase of 16.8% in 2008sales of optical components and 8.5%an increase of 45.4% in 2007.  Overall, sales were impacted by the severe economic recessionof laser system devices and delayed defense procurement which negatively affected demand for the Company’s products.

instrumentation, both as compared to 2010.

Sales toin the Defense and Aerospace sector showed revenuemarket declined by 3.4% to $6,734,000 in 2011 compared to $6,968,000 in 2010. Sales in 2010 also declined by 6.5% to $6,968,000 in 2010 compared to $7,454,000 in 2009 which was also a decline of 27.8% compared to 2008. Although the rate of the declines down by almost 28%are smaller, the Company continued to feel the impact that the economic downturn has had on our customers spending patterns and 21% from 2008 and 2007, respectively.  Sales were $7,454,000, lower by $2,875,000 from 2008 and $2,002,000 from 2007.  Defensedue to changes in government defense spending on products or systems they supply. For instance, defense spending on existing electro-optical systems over the fiscal periodlast three years has slowed, impacting the demand for the Company’s services in manufacturing custom products for its OEM customers.

Sales in the Process Control and Metrology market, sector, the Company’s second largest market, decreasedincreased in 2009 both2011 by 72.7% to $4,752,000 compared to $2,751,000 in 2010. In 2010, sales increase by 17.6% to $2,751,000 compared to $2,339,000 in 2009. In addition, as a percentage of total sales, this sector increased to 36% compared to 25% in 2010 and 21% in relative2009. The increase in sales dollars.  This reflectedwas mainly the result of the increasing sales demand many of our customers experienced for systems they sell containing our products. The increase in sales in 2011 and 2010, as compared to 2009, reflect the severe impact of the economic downturn,recession, that year, which particularly in theaffected demand for our products by our commercial and semi-conductor markets and the customer base that the Company serves.  Sales were $2,339,000 or 21% of total sales compared to sales in 2008 of $4,692,000 or 29% of total sales, and sales in 2007 of $3,760,000 or 25% of total sales.

customers.

The Company serves the non-military laser industry as an OEM supplier of standard and custom optical components and laser accessories. In this sector, 2009This market’s sales declinedincreased to $539,000 from $193,000 in 2010 and $138,000 or 1% of total sales. In 2008, sales were $463,000 or 3% of total sales compared with sales in 2007 of $932,000 or 6% of total sales.2009. The sales declineincreases over the last few years primarily reflectspast two year have principally come from increased demand in the decline in orders from one major customermedical laser industry. The Company includes sales of other products that are not currently large enough to list individually, in this market.

market segment. Sales to customers within the University and National Laboratories market sector increased to $492,000 or 4% of total sales primarily reflecting a large order from one specific customer.  This follows a sales decline in 2008 to $203,000 from $352,000 in 2007.
Other sector salesthese other products have been in the $500,000 to $700,000 range historically and were $716,000 in 2011, $603,000 in 2010, and $628,000 in 2009. Overall, the market for laser systems and other products represented 10% of total sales in 2010 and 7% of total sales in 2010 and 2009, respectively.

Sales to customers within the university and national laboratories market sector decreased in 2011 to $436,000 or 3% of total sales compared with an increase in 2010 to $539,000 or 5% of total sales from $492,000 or 4% of total sales in 2009. Although the results as a percentage of total sales vary slightly from year to year the total dollar amount remained relatively flat at $628,000 in 2009, compared to other sector salesunchanged over the past three years and is dependent on research projects and the availability of $614,000 and $600,000 in 2008 and 2007, respectively.

The Company has refocused its sales and marketing efforts to expand current markets, add to its customer base, increase sales and marketing efforts in the international segment and in developing new products, so as to be positioned to take advantage of new opportunities as economic conditions improve and industry demand strengthens.
funding for such projects.

Bookings

The Company booked new orders totaling $12.9 million in 2011, an increase from $12.3 million in 2010. The increase in 2011 was across all the business sectors that the Company serves and consisted of orders from the new customers and increases from most of our existing customer base. While the timing of the orders placed by customers may vary from quarter to quarter, the second half of the year was only slightly better.

In 2010, the Company booked new orders totaling $12.3 million in 2010, an increase from the $9.5 million in 2009, down from $13.0 million2009. The increase in 2007 and $17.8 million in 2007 reflecting a decline2010 was incurred across all the business sectors that the Company serves. DespiteHowever, a significant portion of the decrease, the Company was able to add several new customers while maintaining most of its existing customer base.

In 2008, the2010 bookings decrease from the prior year was partly attributable to lower orders for legacy INRAD laser accessories and decreased demand for crystal components from one large customer.  Additionally, bookingswere recorded in our MRC Optics business decreased from 2007 levels.  MRC had two large bookings near the end of 2007 which were scheduled to carry through 2008 and into 2009.  In the second half of 2008, MRC orders decreasedthe year as the impactresult of the economic downturn and defense sector slowdown affected our commercial customer’s and they experienced a slowdown in their business activities and demand for its products.  This carried over into 2009.
Bookings in 2007 were up due to increased demand for optical components, mainly in our Laser Optics and MRC Optics brands.  In particular, orders from one large INRADthe new customers and increases from most of our existing customer in the Process Control and Metrology sector and one large Laser Optics OEM customer in the Defense/Aerospace sector contributed significantlybase.

The Company’s backlog as of December 31, 2011 decreased to the increase in 2007$4.9 million from 2006.  One large new Defense/Aerospace OEM was added in 2007 while orders from another declined by 50%.  Additionally, a large new OEM customer in the Process Control and Metrology sector was added in 2007.

13

$5.4 million as of December 31, 2010. The decline in bookings in 2009 affected the Company’s backlog as of December 31, 2009 which decreased towas $4.4 million, down from $6.1 million at December 31, 2008 and $9.4 million at December 31, 2007.
million.

Cost of Goods Sold and Gross Profit Margin

Cost of goods sold as a percentage of sales was 80.5%73.0%, 70.5%77.3% and 60.5%80.5%, for the years ended December 31, 2009, 20082011, 2010 and 2007,2009, respectively. In dollar terms, 20092011 cost of goods sold was $9,615,000 increased from $8,545,000 in 2010 in conjunction with the increase in sales in 2011. Cost of goods sold in 2010 was down 3.9% from $8,897,000 which is down 22.5% from $11,487,000 in 2008, compared with a 32% sales decline over the comparable period.

2009 even though revenues remained unchanged.

The increase in Costcost of Goods Sold percentagegoods sold in 2011 compared to 2010 is primarily due to increases in material costs, manufacturing labor and operating costs. Compared to 2010, material costs increased by $591,000 principally due to product mix which had a higher material costs. In addition, the cost of manufacturing wages and salaries and related fringe benefits increased by $398,000 principally due to the increase in direct labor required to meet demand.

The slight decrease in cost of goods sold in 2010 compared to 2009 is primarily due to declines in labor and operating costs partially offset by an increase in material costs. Compared to 2009, total manufacturing wages and salaries decreased by $332,000 as operations continued to implement process improvements and resulted in a decrease in non-labor operating expenses of $184,000. Conversely, material costs increased by $213,000 for the Company which was mainly due to product mix at our Florida facility.

The increase in cost of goods sold percentagein 2009 compared to 2008 is primarily due to the significant decline in sales volume during the year, net of cost reductions implemented by the Company during the year. Compared to lastthe prior year, material cost as a percentage of sales remained unchanged from 2008 although in dollar terms material costs declined by $913,000, as expected with the lower sales volume levels. Total manufacturing wages and salaries declined by approximately $832,000 but rose by 5.6 percentage points, as a percentage of sales. Non-labor operating costs excluding depreciation also fell in dollar terms in 2009 by approximately $606,000 or 26.7% from 2008, but as a percentage of sales, increased by about 1.1 percentage points from the prior year.

In 2008, Cost of Goods Sold compared to 2007 was up 25.7% from $9,141,000 and was 70.5% of sales compared to 60.5% in 2007.  Approximately 8% of the increase related to higher sales volumes, but the major part of the increase was due to other factors.  Material cost as a percentage of sales increased in 2008 due partly to a change in product/sales mix, including several new OEM products which were weighted towards a higher cost material content than in 2007.  Contributing to this was the conclusion of an agreement with one large OEM customer which included customer supplied materials in 2007 and early 2008.  The Company was required to purchase material for ongoing orders for this customer over the last nine months of 2008 and resulted in an increase in material cost of sales for the year.  Also, production problems during 2007 at our Florida operation resulted in higher than expected material costs from rework requirements, relative to 2008.
Production labor costs, in dollar terms, rose by approximately 32% from 2007.  Increases in employment levels of production personnel to support higher sales volumes, contributed to the higher costs during 2008.  Also, as noted above, production issues which affected material costs, as noted above, also resulted in inefficiencies and excessive rework that negatively impacted labor and overhead costs throughout most of the year.  This also resulted in direct inventory write-offs and increased reserves against work in process during the year which totaled approximately $48,000 and $161,000, respectively.

Gross margin in 20092011 was $2,154,000$3,562,000 or 19.5%27.0% which was downis an increase from 20082010 gross margin of $4,815,000$2,509,000 or 29.5%22.7%. This compares with a gross margin of $5,959,000$2,154,000 or 39.5%19.5% in 2007.

2009.

Selling, General and Administrative Expenses

Selling, general and administrative expenses (“SG&A”) were $3,278,000$3,255,000 in 2009, down $580,0002011, an increase of $150,000 or 15%4.8% from 2008, and2010. As a percentage of sales, SG&A expenses decreased to 24.7% of 2011 sales compared to 28.1% of sales in 2010. The decline in SG&A expenses, as a percentage of sales, representedreflects the impact of cost reductions in SG&A salaries and wages and fringe benefits from personnel reductions started in the second half of the prior year, offset by higher expenses related to the increase in sales in the current year.

SG&A expenses were $3,105,000 in 2010, down $174,000 or 5.3% from 2009. As a percentage of sales, SG&A expenses were 28.1% of 2010 sales compared to 29.7% of sales in 2009 and 23.7% of sales in 2008.2009. The decline in dollar expense resulted mainly from reductions in SG&A salaries and wages and fringe benefits reflectingfrom personnel reductions implemented in the first quartersecond half of 2009the year and continued cost management of other SG&A expenses throughout the year.  Overall SG&A salary and wages decreased by 14.5% over

Operating Income (Loss)

The Company had an operating income of $307,000 in 2011 which was an improvement after the prior year.  Non-payroll SG&A expenses excluding depreciation also declined by 15.5% compared to 2008.

Selling, general and administrative expenses in 2008 increased in dollar terms from those in 2007 by $296,000, or 8.3%.  Higher wage, recruitment and relocation costs related to new personnellosses incurred during the year contributed topast two years. In 2010, the increase. In addition, sales travel and trade show expenses related to increased business development activity increased during the year. Travel expenses also rose as a result of more frequent travel by corporate staff between our operation centers in New Jersey and Florida.  Stock-based compensation expenses rose due to sign-on grants to new employees and the expense associated with fully vested stock option awards to the Company’s former CEO.  These were offset by reductions in commission expenses to independent sales agents and lower consulting costs.  Increases in SG&A salaries and wages reflected both annual SG&A pay increases as well as one-time living allowances paid to replacement sales staff brought on at the end of 2007.
Operating (Loss) Income
The Company had an operating loss of $2,682,000$596,000 and in 2009 after recordingthe Company had an operating loss of $1,124,000 excluding a non-cash charge for the impairment of goodwill of $1,558,000, as discussed$1,558,000. The losses in Note 4 of the Company’s Consolidated Financial Statements.  Excluding the charge for goodwill impairment, the Company had an operating loss of $1,124,0002010 and 2009, primarily, reflecting thereflect a significant decrease in sales as discussed above.
Thedue to the economic recession which severely impacted the Company had operating income of $957,000 in 2008 which was a decline from $2,397,000 in the previous year as a result of the increases in the Company’s cost of sales and lower margins related to production inefficiencies and increased labor and overhead costs in our MRC business unit, as well as a less profitable sales mix and higher selling, general and administrative costs.
14

Operating income in 2007 was $2,397,000, or 15.9% of sales, up $1,481,000 or 161% from the prior year.
during this period.

Other Income and Expenses

Net interest expense of $130,000 in 2009 declined 23.5%2011 decreased 5.3% from $170,000$138,000 in 2008.2010. Interest expense was $167,000$163,000 in 20092011 compared to $236,000$164,000 in 2008 which reflects2010which is the positive impactresult of the Company’s continued reduction innormal scheduled debt and long term notes.repayments. Interest income for 20092011 increased to $33,000 from $26,000 in 2010 mainly as a result of changes in short term cash balances and bank money market interest rates.

Net interest expense of $138,000 in 2010 increased 5.7% from $130,000 in 2009. Interest expense was $37,000$164,000 in 2010 compared to $167,000 in 2009which is the result of the Company’s normal scheduled debt repayments. Interest income for 2010 was $26,000 down from $66,000$38,000 in 20082009 mainly as a result of reductions in bank interest rates on invested cash balances.

Net interest expense of $170,000 in 2008 was down 34.8% from $261,000 in 2007.  Interest expense was $236,000 compared to $424,000 in 2007.  The reduction in net interest expense reflects

In 2011, the positive impact ofCompany sold surplus equipment and recorded a loss $1,003 on the Company’s continued reduction in debtsales.

Income Taxes

In 2011, the Company recorded a current provision for state tax and long term notes and capital lease balances due to both scheduled amortization and accelerated principal re-payments, including the $1,700,000 subordinated convertible debtfederal alternative minimum tax in the first quarteramount of 2008.  Interest income for 2008 was $66,000, down from $163,000 in 2007 as the result of lower cash balances available for investment during the year$11,000. In 2010 and reductions in bank interest rates on invested cash balances.

Income Taxes
In 2009, the Company did not record a current provision for either state tax or federal alternative minimum tax due to the losses incurred for both income tax and financial reporting purposes.
In 2008, the Company recorded a current provision for state tax and federal alternative minimum tax of $100,000 and $5,000, respectively, after the application of net operating losses of $523,000 against federal tax.  In 2007, the Company recorded income tax expense in the amount of $250,000 after utilizing net operating losses of approximately $2,700,000 to offset federal taxes payable.

The Company recognizes deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. Deferred tax liabilities and assets are determined based on the difference between the financial statements carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

At December 31, 2009,2011, the Company had a total net deferred tax asset balance of $2,857,000,$2,860,000, an increase of $716,000$73,000 from 2008 primarilya $2,787,000 in 2010 and $344,000 from the increase to the net operating loss carry forward position that resulted for the losses incurred$2,516,000 in 2009 and depreciation.   Although the Company believes that the current year’s losses were caused by the recent economic conditions, the Company has increased the valuation allowance to $2,449,000 to fully offset the current year’s increase in the deferred tax asset.

2009.

As of December 31, 20092011, 2010 and 2008,2009, the Company recognized a portion of the net deferred tax assets in the amount of $408,000 which the Company’s management is reasonably assured will be fully utilized in future periods. Although the Company’s current year financial results were positively affected by the strengthening economy, primarily in the second half of the year, we increased the valuation allowance to $2,452,000 to fully offset the increase in the deferred tax asset. In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income that is consistent with the plans and estimates that management is using to manage the underlying business.

The Company’s valuation allowance as of December 31, 20092011 will be maintained until management concludes that it is more likely than not that the remaining deferred tax assets will be realized. When sufficient positive evidence exists, the Company’s income tax expense will be reduced by the decrease in its valuation allowance. An increase or reversal of the Company’s valuation allowance could have a significant negative or positive impact on the Company’s future earnings.

At December 31, 2007, the Company had

Net Income (Loss)

In 2011, net income was $165,000, compared to a net deferred tax assetloss of approximately $2,041,000,$734,000 in 2010 primarily as a result of higher sales and the primary componentpositive leveraging of which was net operating loss carry forwards.  Through December 31, 2007, the Company had established a valuation allowance to fully offset this deferred tax asset in the event the tax asset will not be realized in the future.   The Company determined that basedhigher sales on a recent history of consistent earnings and future income projections, a full valuation allowance was no longer required.  Accordingly, during the year ended December 31, 2008, the Company reduced the valuation allowance and recognized a deferred tax benefit available from the Company’s net operating loss carry forward position of $408,000 based onrelatively fixed cost structure. In 2009, the effective federal tax rate of 34%.  This resulted in the Company recording a net benefit from income taxes of $303,000 after offsetting the deferred tax benefit against the current tax provision.  At December 31, 2008, the Company had net deferred tax asset balance of $2,141,000 offset by a valuation allowance of $1,733,000.

Net (Loss) Income
The Company had a net loss of $2,800,000 in 2009 attributable towhich included a $1,558,000 non-cash charge for goodwill impairment, as well as lowerimpairment. Both 2010 and 2009 results were impacted by the reduced sales volumes during the recession and reducedthe negative impact on profit margins, which werewas somewhat offset by manufacturing and SG&A cost reductions.   Net incomereductions in 2008 was $1,098,000, down $782,000 from net income of $1,880,000.  
Net (Loss) Income Applicable to Common Shareholders2010 and (Loss) Earnings per Common Share
Net (loss) income applicable to common shareholders is arrived at after deducting the value of the stock dividends issued by the Company to the holders of its Series A and Series B convertible preferred stock. The dividend value is calculated by reference to the market price of the common shares on the dividend distribution date.  The number of common shares issued in settlement of the dividend is determined based on the coupon rate of the preferred shares, the total shares outstanding, and the conversion price of each series of preferred shares.
15

In 2009 and 2008, the Company did not pay common stock dividends as all Preferred Series A and B stock had been redeemed in the prior year.  In April of 2007 and 2006, the Company distributed common stock dividends valued at $238,200 and $234,500, respectively to the holders of its Series A and B convertible preferred stock.
In 2007, all of the shares of the Series A convertible preferred stock and approximately 98% of the shares of the Series B convertible preferred stock were converted by the preferred shareholders into 812,800 shares of the Company’s common stock.  The stock of the remaining holder of 50 shares of Series B convertible preferred stock was redeemed by the Company on the payment of $50,000, the liquidation value, plus an accrued stock dividend of $5,000.
As a result, net loss applicable to common shareholders in 2009 was $2,800,000 or $(0.25) per share basic and diluted, compared to net income applicable to common shareholders in 2008 which was $1,098,000, or $0.10 per share basic and $0.08 per share diluted.  Net income applicable to common shareholders for the same period in 2007 was $1,642,000, and earnings per share were $0.19 per share basic and $0.13 per share diluted.
2009.

Liquidity and Capital Resources

A major

The Company’s primary source of cash in recent years has been from operating cash flows. Other sources of cash include proceeds received from the exercise of stock options short-term borrowing, and issuance of common stock. The Company’s major uses of cash in the past three years have been for capital expenditures and for repayment and servicing of outstanding debt.

debt and accrued interest.

Supplemental information pertaining to our source and use of cash is presented below:


Selected Sources (uses) of cash Years ended December 31, 
  2009  2008  2007 
  (In thousands) 
Net cash provided by operations $815  $548  $3,001 
             
Net Proceeds from issuance of common stock, exercise of stock options and warrants  162   1,064   395 
             
Capital Expenditures  (211)  (785)  (247)
             
Principal payments on lease obligations     (47)  (196)
             
Principal payments on debt obligations  (137)  (1,715)  (1,647)

Selected Sources (uses) of cash Years ended December 31, 
  2011  2010  2009 
  (In thousands) 
Net cash (used) provided by operations $(358) $576  $815 
             
Net Proceeds from issuance of common stock, exercise of stock options and warrants  18   7   162 
             
Capital Expenditures  (304)  (278)  (211)
             
Precious Metals  (318)     (37)
             
Principal payments on debt obligations  (9)  (9)  (137)

In 2011, the Company used cash to accelerate the payment of accrued interest of $1,125,000 on Related Party Convertible Notes Payable, as well as paying current interest on debt obligations, and financing capital expenditures. In 2010 and 2009, the Company primarily used excess cash to finance capital expenditures and repay outstanding debtdebt.

In 2011, proceeds from the exercise of 20,000 stock options and finance capital expenditures.issuance of 6,239 common shares totaled $18,260. In 20082010, proceeds from the exercise of 10,000 stock options and 2007, excess cash was used to retire the Company’s convertible preferredissuance of 5,906 common shares in addition to accelerating the repayment of debt and financing of capital expenditures.  

totaled $7,102. During 2009, 84,500 stock options were exercised for proceeds of $96,600$96,575 at a weighted exercise price of $1.14 per share and converted into an equivalent number of shares of the Company’s common stock.  This compares with proceeds from the exercise of stock options of $285,000 in 2008, with 182,000 stock options exercised at a weighted average exercise price of approximately $1.42 per share.  By comparison, in 2007, proceeds from the exercise of stock options were $445,000 with 651,100 stock options exercised at a weighted average exercise price of $0.68 each and converted into an equivalent number of shares of common stock

During 2009, a total of 50,000 warrants issued pursuant to a 2004 private placement were exercised by warrant holders with a total exercise price of $67,500. Also in July 2009, 893,790 warrants with an exercise price of $1.35 expired unexercised. These warrants were originally issued as part of a private placement of common stock in 2004 in which2004.

In March 2011, the maturity dates of a $1,500,000 Subordinated Convertible Promissory Note to Clarex Limited (“Clarex”) and a $1,000,000 Subordinated Convertible Promissory Note to an affiliate of Clarex were extended to April 1, 2013. The remaining terms and conditions of the notes were unchanged. These notes were previously issued on April 1, 2009 and had a maturity date of April 1, 2011. The notes bear interest at 6%. Interest accrues yearly, is payable on maturity and unpaid interest along with principal may be converted into securities of the Company issued 1,581,000as follows: The notes are convertible in the aggregate into 1,500,000 Units and 1,000,000 Units, respectively, with each unit consisting of 1,581,000 sharesone share of common stock and warrants, exercisable through August 2009,one warrant. Each warrant allows the holder to acquire an additional 1,185,7500.75 shares of common stock at a price of $1.35 per share.share and have an expiration date of April 1, 2016. Clarex is a significant shareholder of the Company.

During 2011, the Company paid a total of $1,125,000 of accrued interest, on the two notes. In addition, 276,675 warrants were issued to the agent for the private placement.  During 2008, 518,635 warrants from the private placement were exercised by warrant holders.  A total of 375,520 warrants with a total exercise price of $507,000 were surrendered to the Company paid $150,000 of current interest on the notes in exchange2011. The Company intends to stay current with interest payments for amounts that would accrue against these notes. Therefore, the issuanceCompany expects to make a payment of 375,250 shares$37,500 each quarter in 2012 and through the maturity date to satisfy the amounts of the Company’s common stock.  An additional 142,385 placement agent warrants were exercised using a cashless feature available for these warrants, in exchange for 89,702 shares of the Company’s common stock.

16

accrued interest each quarter.  

In May 2009, the Company repaid a Promissory Note prior to maturity, in the amount of $125,000 and accrued interest of $4,212, which represented the balance of a Note issued by the Company as part of the purchase price of MRC in 2004, to the sole shareholder of the acquired company.

In March 2009, the maturity date of a $1,000,000 Subordinated Convertible Promissory Note to Clarex Limited (“Clarex”), a major shareholder and debt holder, was extended to April 1, 2011.  The note bears interest at 6% and was originally due in January 2006, extended to December 31, 2008 and subsequently again to April 1, 2009.  Interest accrues yearly and along with principal may be converted into common stock, (and/or securities convertible into common shares).  The Note is convertible into 1,000,000 Units consisting of 1,000,000 shares of common stock and warrants.  The warrants had an original expiration date of August 2009 and allowed the holder to acquire 750,000 shares of common stock at a price of $1.35 per share.  The expiration date of the warrants under the conversion terms have been extended to April 1, 2014.
  In March of 2009, the maturity date of a $1,500,000 Subordinated Convertible Promissory Note bearing interest at 6% was extended to April 1, 2011.  The note was originally due in January 2006 and was subsequently extended to April 1, 2009.  Interest accrues yearly and along with principal may be converted into Common Stock, and/or securities convertible into Common Stock.  The note is convertible into 1,500,000 Units consisting of 1,500,000 shares of Common Stock and Warrants to acquire 1,125,000 shares of Common stock at a price of $1.35 per share up to August 2009. The original expiration date of warrants of August 2009 was extended to April 1, 2014. The holder of the note is a major shareholder of the Company.
On January 29, 2008, the Company repaid in full a $1,700,000 Secured Promissory Note held by Clarex, including accrued interest of $477,444.  The note was originally issued in June 2003 for a period of 18 months at an interest rate of 6% per annum and was secured by all assets of the Company.  As additional consideration for the note, the Company issued 200,000 warrants to Clarex.  In 2004, the note was extended for an additional 36 months and the Company issued 200,000 additional warrants to Clarex.  The initial and subsequent warrants were exercisable at $0.425 per share and $1.08 per share, respectively, and had an expiration date of March 31, 2008 and May 18, 2008.  The note was extended again, to December 31, 2008, without issuance of warrants or any other further consideration.
In March, 2008, Clarex elected to exercise the 200,000 warrants expiring on March 31, 2008 and the Company issued 200,000 shares of its common stock for proceeds of $85,000.
In May, 2008, Clarex exercised the remaining 200,000 warrants set to expire on May 18, 2008 for $216,000 and the Company issued 200,000 shares of its common stock.
In December 2007, the Company repaid the outstanding balance of $554,600 principal and accrued interest of $1,740 of the original $700,000 loan from Clarex, retiring this debt.  The loan was originally issued in February 2006 to provide the Company with financing to fund the acquisition of certain capital assets required for expanded capabilities to meet customer demand. The terms called for repayment in equal monthly installments, including interest and principal, commencing March 2006, until maturity in March 2013 at an annual interest rate of 6.75% and allowed for early repayment.
On June 28, 2007, the Company accelerated payment of $500,000 on the outstanding balance of a $1,000,000 Subordinated Convertible Promissory Note and subsequently, on September 17, 2007, paid the remaining balance of principal and interest on this note, in full, in the amount of $697,000, consisting of $500,000 in remaining principal and $197,000 in accrued interest.  The Company originally received $1,000,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note in 2004.  The note had an interest rate of 6% and was initially due on March 31, 2007, but its term was extended in early 2007 to March 31, 2008.  Interest accrued yearly and along with principal was convertible into Common Stock, (and/or securities convertible into common shares).  The note was convertible into 1,000,000 Units consisting of 1,000,000 shares of Common Stock and Warrants, exercisable through July 2009, to acquire 750,000 shares of Common Stock at a price of $1.35 per share.  The note holder was a major shareholder of the Company.
On April 16, 2007, the Company called for the full redemption of its $500,000 Series A 10% Convertible Preferred Stock (the “Series A”).  On April 30, 2007, Clarex Limited, the holder of all the shares of the Series A, notified the Company that it had decided to convert all 500 preferred shares into 500,000 shares of the Company’s common stock, in accordance with the Series A agreement.
On October 25, 2007, two principal holders, two outside Directors, and the Company’s CEO, notified the Company they were exercising their right to convert their shares of the Company’s $2,082,000 Series B 10% Convertible Preferred Stock (the “Series B”) into common stock at the specified conversion price of $2.50 per share.  In the aggregate, these holder’s shares of the Series B represented 1,560 shares or 75% of the total of 2,082 issued and outstanding Series B shares.  Subsequently, on October 29, the Company issued a call for the redemption of the remaining balance of 522 issued and outstanding Series B shares on November 29, 2007.  The 10 holders of these shares had the option of converting their shares into common stock prior to the redemption date.  Nine holders elected to convert, and the remaining holder elected to redeem the preferred shares for cash and a final stock dividend accrued to the redemption date.  In all, the Series B was converted into 812,800 shares of common stock through conversion, and through redemption into a cash payment of $50,000 and an accrued final stock dividend of 1,332 shares of common stock.
17

In 2009, non-cash investments in the amountcertificate of deposits totaling $800,000 were redeemed compared to a purchasean investment of $800,000 in certificates of deposit 2008.

Capital

In 2011, capital expenditures of $304,000 were primarily to replace or refurbish both operating facilities, purchase equipment upgrades to the computer information system and manufacturing equipment. In 2011, the company purchased additional manufacturing tools made from platinum at a net cost of $318,000 to further increase our crystal growth capacity at our Northvale, New Jersey facility.

The Company had capital expenditures in 2010 in the amount of $278,000, primarily to replace or refurbish manufacturing equipment and for additional equipment required to increase our crystal growth capacity at our Northvale, New Jersey location. For the year ended December 31, 2009 werecapital expenditures of $211,000 and included planned expenditures primarily for manufacturing and optical testing equipment that increaseddesigned to increase production capacityefficiency at our Northvale, New Jersey location. DuringIn addition, the year,Company purchased a review program for planned capital expendituresmanufacturing tool made from platinum at a net cost of $53,000. The cost was instituted, in order to identify and defer expenditures, where practical, to minimize the impact on the Company’s cash flows.  Offsetting the impact of capital expenditures on cash flows was the receipt of $5,000offset by proceeds from the sale of fully depreciated surplus manufacturing equipment during the fourth quarter of 2009.  In 2009, the Company purchased precious metal manufacturing toolsplatinum for $53,000 offset by the receipt of $16,000, for similar precious metal tools that were sold as part of the purchase.

This comparespurchase arrangement.

In 2011, cash decreased by $965,000 compared to capital expendituresan increase of $296,000 in 2008 and 20072010. In 2010, cash increased by $296,000 compared to an increase of approximately $784,000 and $247,000, respectively.  In 2008, capital expenditures were primarily$597,000 for increased production capacity and capability in both our Sarasota, Florida and Northvale, New Jersey locations.  Offsetting the impact of capital expenditures on cash flows was the receipt of $10,0002009 (excluding proceeds from the saleredemption of surplus manufacturing equipment during the second quarter of 2008.

As a result of the above, cash and cash equivalents increased by $1,397,000 for 2009. In  2008, cash and cash equivalents decreased by $1,724,000 reflecting lower cash provided from operations and after cash used in investing activities for capital expenditures and increased cash used in financing activities related to the Company’s repayment of convertible debt.  The Company had certificates of deposit with terms greater than three months and showed these separately from cash and cash equivalents onin the balance sheet.  For 2007, cash and cash equivalents increased by $1,318,000 to $4,396,000, after net cash outlays for debt repayments and redemptionsamount of $1,697,000.
$800,000).

A summary of the Company’s contractual cash obligations at December 31, 20092011 is as follows:

 
 
Contractual Obligations
 Total  
Less than
1 Year
  1-3 Years  
4-5
Years
  
Greater
Than 5
Years
 
  (In thousands) 
Convertible notes payable $2,500  $  $2,500  $  $ 
Notes payable-other, including interest  550   23   69   46   412 
Operating leases (1)  451   451          
Total contractual cash obligations $3,501  $474  $2,569  $46  $412 

 (1)  Excludes all future lease renewal options available to Company and which have not yet been exercised.

Contractual Obligations Total  Less than
1 Year
  1-3 Years  4-5
Years
  Greater
Than 5
Years
 
  (In thousands) 
Convertible notes payable $2,500  $  $2,500  $  $ 
Notes payable-other, including interest  503   23   69   46   365 
Operating leases  1,086   440   646       
Total contractual cash obligations $5,167  $503  $4,229  $46  $389 

Overview of Financial Condition

As shown in the accompanying financial statements, the Company reported a net income of $165,000 in 2011 compared to a net loss of $734,000 and $2,800,000 whichin 2010 and 2009, respectively. The net loss in 2009 included a non-cash charge for goodwill of $1,558,000$1,558,000. During 2011, the Company’s working capital requirements were provided by cash from operations and recorded net income of $1,098,000 in 2008available cash balances. In 2010 and $1,880,000 in 2007.  During 2009, 2008 and 2007, the Company’s working capital requirements were provided by positive cash flow from its operations.

Net

In 2011, net cash used by operations was $358,000 compared to net cash provided by operations was $815,000of $576,000 in 2009, $548,000 in 2008 and $3,001,000 in 2007.2010. The increase in cash provided by operationsdecrease was primarily the results of the net improvementchanges in working capital requirements, which includesresulted from the payment of accrued interest on the Related Party Convertible Note Payable, an increase in inventory (excluding reserve) during the year and a decrease in customer advances, offset by a decrease in accounts receivable and inventory (excluding reserves) offset by an increase in accounts payable and accrued liabilities and customer advances, and offset by a decrease from the net loss, after adjusting for the non-cash charge for goodwill.liabilities. The Company’s management expects that future cash flow from operations and its existing cash reserves will provide adequate liquidity for the Company’s operations and working capital requirements in 2010.

2012.

Off-Balance Sheet Arrangements

The Company did not have any off-balance sheet arrangements at December 31, 20092011 and 2008.

2010.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk
The Company believes that it has limited exposure to changes in interest rates from investments in certain money market accounts.  The Company does not utilize derivative instruments or other market risk sensitive instruments to manage exposure to interest rate changes.
18

Item 7A.Quantitative and Qualitative Disclosures about Market Risk

N/A

Item 8. Financial Statements and Supplementary Data
Item 8.Financial Statements and Supplementary Data

The financial statements and supplementary financial information required to be filed under this Item are presented commencing on page 24 of the Annual Report on Form 10-K, and are incorporated herein by reference.

Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9.Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

None

Item 9A. Controls and Procedures
a)  Evaluation of Disclosure Controls and Procedures
Item 9A.Controls and Procedures

a)Evaluation of Disclosure Controls and Procedures

The Company’s management, including the Chief Executive Officer and the Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Annual Report on Form 10-K. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures as of December 31, 20092011 are effective to ensure that information required to be disclosed in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to the Company's management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding disclosure.

b)  Management’s Annual Report on Internal Control over Financial Reporting

b)Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining an adequate system of internal control over financial reporting. Our internal control over financial reporting includes those policies and procedures that:

·pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

·provide reasonable assurance that transactions are recorded as necessary to permit preparation of our financial statements in accordance with generally accepted accounting principles in the United States, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

·provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

Our management assessed the effectiveness of our system of internal control over financial reporting as of December 31, 2009.2011. In making this assessment, management used the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our assessment and the criteria set forth by COSO, management has concluded that the Company maintained effective internal control over financial reporting as of December 31, 2009.

Our annual report on Form 10-K does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting.  Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report.
c)  Changes in Internal Control over Financial Reporting
2011.

c)Changes in Internal Control over Financial Reporting

There have been no significant changes in the Company’s internal control over financial reporting identified in connection with the evaluation that occurred during the Company’s last fiscal quarter that have materially affected, or that are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

Item 9B Other Information
Item 9BOther Information

None

19

PART III

Item 10. Directors and Executive Officers of the Registrant and Corporate Governance
Item 10.Directors and Executive Officers of the Registrant and Corporate Governance

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20102012 Annual Meeting of Stockholders.

Item 11. Executive Compensation
Item 11.Executive Compensation

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20102012 Annual Meeting of Stockholders.

Item 12. Security Ownership of Certain Beneficial Owners and Management
Item 12.Security Ownership of Certain Beneficial Owners and Management

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20102012 Annual Meeting of Stockholders.

Item 13. Certain Relationships and Related Transactions
Item 13.Certain Relationships and Related Transactions

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20102012 Annual Meeting of Stockholders.

Item 14. Principal Accounting Fees and Services
Item 14.Principal Accountant Fees and Services

The information required under this item is incorporated by reference to the Company’s Proxy Statement for the 20102012 Annual Meeting of Stockholders.

20

PART IV

Item 15. Exhibits and Financial Statement Schedules
Item 15.Exhibits and Financial Statement Schedules

(a) (1)   Financial Statements.

Reference is made to the Index to Financial Statements and Financial Statement Schedule commencing on Page 24.

(a) (2)   Financial Statement Schedule.

Reference is made to the Index to Financial Statements and Financial Statement Schedule on Page 24. All other schedules have been omitted because the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the Financial Statements or Notes thereto.

(a) (3)Exhibits.

Exhibit No. Description of Exhibit
2.1Stock Purchase Agreement between Photonic Products Group, Inc., MRC Precision Metal Optics and Frank E. Montone (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 25, 2004)
   
3.1 Restated Certificate of Incorporation of Photonics Products Group, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
3.2 By-Laws of Photonic Products Group, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
3.3 Certificate of Amendment to Restated Certificate of Incorporation of Photonics Products Group, Inc., dated June 2, 2010 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 7, 2010).
3.4Certificate of Amendment to Restated Certificate of Incorporation of Photonics Products Group, Inc., dated January 23, 2012 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on January 23, 2012).
4.1 Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.2Form of Warrants issued pursuant to June 2004 Private Placement (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.3Form of Placement Agent Warrants issued pursuant to June 2004 Private Placement (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.4 Promissory Note Dated June 30, 2003 held by Clarex, Ltd. (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.54.3 Subordinated Convertible Promissory Note dated April 1, 2004 held by Clarex, Ltd. (incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.6Subordinated Convertible Promissory Note dated October 31, 2003 held by Clarex, Ltd. (incorporated by reference to Exhibit 4.6 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.7Subordinated Convertible Promissory Note dated December 31, 2002 held by Welland, Ltd. (incorporated by reference to Exhibit 4.7 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.84.4 Warrant dated March 31, 2004 issued to Clarex, Ltd. (incorporated by reference to Exhibit 10.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.94.5 Warrant dated May 19, 2004 issued to Clarex, Ltd. (incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
4.10Extension of Promissory Note dated February 15, 2008 originally issued to Clarex, Ltd. on October 31, 2003 (incorporated by reference to Exhibit 4.10 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2008)
4.11Extension of Promissory Note dated February 15, 2008 originally issued to Welland, Ltd. on December 31, 2002 (incorporated by reference to Exhibit 4.11 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2008)
4.124.6 Subordinated Convertible Promissory Note dated April 1, 2009 held by Clarex, Ltd. (which supersedes documents 4.6 and 4.10) (incorporated by reference to Exhibit 4.12 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2009)
4.134.7 Subordinated Convertible Promissory Note dated April 1, 2009 held by Welland, Ltd.  (which supersedes documents 4.7 and 4.11)  (incorporated by reference to Exhibit 4.13 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2009)
4.8 Subordinated Convertible Promissory Note dated April 1, 2011 held by Clarex, Ltd. (which will supersede document 4.10) (incorporated by reference to Exhibit 4.12 to the Company’s Annual Report on 10-K filed with the Securities and Exchange Commission on March 31, 2011) 
4.9Subordinated Convertible Promissory Note dated April 1, 2011 held by Welland, Ltd. (which will supersede document 4.10)  (incorporated by reference to Exhibit 4.13 to the Company’s Annual Report on 10-K filed with the Securities and Exchange Commission on March 31, 2011) 
10.1 2000 Equity Compensation Program (incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 25, 2004)
10.2 Daniel Lehrfeld Employment Contract, dated October 20, 19992010 Equity Compensation Program (incorporated by reference to Exhibit 10.4B to the Company’s RegistrationProxy Statement on Form S-1for the 2010 Meeting of Stockholders filed with the Securities and Exchange Commission on August 25, 2004)
April 30, 2010)
14.1 Code of Ethics (incorporated by reference to Exhibit 14.1 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2006)
21.1 List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2006)
21

23.1 Consent of Holtz Rubenstein Reminick LLP Independent Registered Public Accounting Firm
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
22


 PHOTONIC PRODUCTS GROUP,IRAD OPTICS, INC.
   
 By:/s/ Joseph J. Rutherford 
  Joseph J. Rutherford
  Chief Executive Officer
  
 Dated: March 31, 201030, 2012

Signature Title Date
     
/s/ Jan M. Winston Chairman of the Board March 31, 201030, 2012
Jan M. Winston of Directors
  
     
/s/ Luke P. LaValle, Jr. Director March 31, 201030, 2012
Luke P. LaValle, Jr.
/s/ Thomas H. LenaghDirectorMarch 31, 2010
Thomas H. Lenagh
    
     
/s/ Dennis G. Romano Director March 31, 201030, 2012
Dennis G. Romano
    
     
/s/ N.E. Rick Strandlund Director March 31, 201030, 2012
N.E. Rick Strandlund
    
     
/s/ Joseph J. Rutherford President, Chief Executive Officer March 31, 201030, 2012
Joseph J. Rutherford and Director
  
     
/s/ William J. Foote Chief Financial Officer, Secretary and March 31, 201030, 2012
William J. Foote Treasurer  

21
 



 Page
Page 
Report of Independent Registered Public Accounting Firm2523
  
Consolidated balance sheetsBalance Sheets as of December 31, 20092011 and 200820102624
  
Consolidated statementsStatements of operationsOperations for each of the three years in the period ended December 31, 200920112725
  
Consolidated statementsStatements of shareholders’ equityShareholders’ Equity for each of the three years in the period ended December 31, 200920112826
  
Consolidated statementsStatements of cash flowsCash Flows for each of the three years in the period ended December 31, 200920112927
  
Notes to consolidated financial statements30-4328-40
  
Schedule II – Valuation and Qualifying Accounts4441









  December 31, 
  2009  2008 
Assets      
Current assets:      
Cash and cash equivalents $4,069,310  $2,672,087 
Certificates of deposit     800,000 
Accounts receivable (after allowance for doubtful accounts of $15,000 in 2009 and 2008)  1,927,672   2,810,602 
Inventories, net  2,265,973   2,732,336 
Other current assets  164,081   188,084 
Total Current Assets  8,427,036   9,203,109 
Plant and equipment:        
Plant and equipment at cost  14,604,728   14,445,027 
Less: Accumulated depreciation and amortization  (12,016,247)  (11,139,771)
Total plant and equipment  2,588,481   3,305,256 
Precious Metals  157,443   112,851 
Deferred Income Taxes  408,000   408,000 
Goodwill  311,572   1,869,646 
Intangible Assets, net of accumulated amortization  673,016   751,580 
Other Assets  45,192   81,707 
Total Assets $12,610,740  $15,732,149 
         
Liabilities and Shareholders’ Equity        
Current Liabilities:        
Current portion of notes payable -other $9,000  $136,892 
Accounts payable and accrued liabilities  1,632,650   2,160,665 
Customer advances  346,429   456,754 
Total Current Liabilities  1,988,079   2,754,311 
         
Related Party Convertible Notes Payable  2,500,000   2,500,000 
Notes Payable – Other, net of current portion  344,946   353,663 
Total Liabilities  4,833,025   5,607,974 
         
Commitments        
         
Shareholders’ equity:        
    Common stock: $.01 par value; 60,000,000 authorized shares 11,443,347 issued at December 31, 2009 and 11,230,678 issued at December 31, 2008  114,433   112,306 
Capital in excess of par value  17,073,871   16,622,466 
Accumulated deficit  (9,395,639)  (6,595,647)
   7,792,665   10,139,125 
         
Less - Common stock in treasury, at cost (4,600 shares)  (14,950)  (14,950)
Total Shareholders’ Equity  7,777,715   10,124,175 
Total Liabilities and Shareholders’ Equity $12,610,740  $15,732,149 


  December 31, 
  2011  2010 
Assets        
Current assets:        
Cash and cash equivalents $3,400,205  $4,365,045 
Accounts receivable (net of allowance for doubtful accounts of $15,000 in 2011 and 2010)  2,052,887   2,224,592 
Inventories, net  2,909,520   2,390,876 
Other current assets  185,298   119,243 
Total Current Assets  8,547,910   9,099,756 
Plant and equipment:        
Plant and equipment at cost  15,172,428   14,879,508 
Less: Accumulated depreciation and amortization  (13,629,311)  (12,876,163)
Total plant and equipment  1,543,117   2,003,345 
Precious Metals  474,960   157,443 
Deferred Income Taxes  408,000   408,000 
Goodwill  311,572   311,572 
Intangible Assets, net of accumulated amortization  515,888   594,452 
Other Assets  36,556   47,235 
Total Assets $11,838,003  $12,621,803 
         
Liabilities and Shareholders’ Equity        
Current Liabilities:        
Current portion of notes payable -other $9,800  $9,000 
Accounts payable and accrued liabilities  877,757   836,190 
Customer advances  266,818   441,987 
Total Current Liabilities  1,154,375   1,287,177 
         
Related Party Convertible Notes Payable  2,500,000   2,500,000 
Accrued Interest on Related Party Convertible Note Payable     1,125,000 
Notes Payable – Other, net of current portion  325,633   335,874 
Total Liabilities  3,980,008   5,248,051 
         
Commitments        
         
Shareholders’ equity:        
Common stock: $.01 par value; 60,000,000 authorized shares 11,713,564 issued at December 31, 2011 and 11,562,656 issued at December 31, 2010  117,137   115,626 
Capital in excess of par value  17,720,514   17,402,528 
Accumulated deficit  (9,964,706)  (10,129,452)
   7,872,945   7,388,702 
         
Less - Common stock in treasury, at cost (4,600 shares)  (14,950)  (14,950)
Total Shareholders’ Equity  7,857,995   7,373,752 
Total Liabilities and Shareholders’ Equity $11,838,003  $12,621,803 

See notes to consolidated financial statements

26


PHOTONIC PRODUCTS GROUP, INC

INRAD OPTICS, INC. AND SUBSIDIARIES



  Years Ended December 31, 
  2009  2008  2007 
Revenues         
Net sales $11,051,127  $16,301,209  $15,099,878 
             
Cost and expenses            
Cost of goods sold  8,896,539   11,486,620   9,141,049 
Selling, general and administrative expense  3,278,161   3,857,805   3,561,570 
Goodwill Impairment Charge  1,558,074       
   13,732,774   15,344,425   12,702,619 
             
Operating (loss) income  (2,681,647)  956,784   2,397,259 
             
Other income (expense)            
Interest expense, net  (130,387)  (170,476)  (261,327)
Gain on sale of plant and equipment  4,671   9,113    
Gain (loss) on sale of precious metals  7,371      (5,851
   (118,345)  (161,363)  (267,178)
             
(Loss) income before income taxes and preferred stock dividends  (2,799,992)  795,421   2,130,081 
             
Income tax benefit (provision)     303,000   (250,000
             
Net (loss) income  (2,799,992)  1,098,421   1,880,081 
             
Preferred stock dividends        (238,167)
             
Net (loss) income applicable to common shareholders $(2,799,992) $1,098,421  $1,641,914 
             
Net (loss) income per share - basic $(0.25) $0.10  $0.19 
             
Net (loss) income per share - diluted $(0.25) $0.08  $0.13 
             
Weighted average shares outstanding - basic  11,331,258   10,902,061   8,609,822 
             
Weighted average shares outstanding – diluted  11,331,258   15,619,304   13,777,114 
             

  Years Ended December 31, 
  2011  2010  2009 
Revenues            
Net sales $13,177,194  $11,054,178  $11,051,127 
             
Cost and expenses            
Cost of goods sold  9,614,875   8,545,153   8,896,539 
Selling, general and administrative expense  3,255,073   3,105,063   3,278,161 
Goodwill Impairment        1,558,074 
   12,869,948   11,650,216   13,732,774 
             
Operating (loss) income  307,246   (596,038)  (2,681,647)
             
Other (expense) income            
Interest expense, net  (130,497)  (137,775)  (130,387)
(Loss) gain on sale of plant and equipment  (1,003)     4,671 
Gain on sale of precious metals        7,371 
   (131,500)  (137,775)  (118,345)
             
Income (loss) before income taxes  175,746   (733,813)  (2,799,992)
             
Income tax provision  11,000       
             
Net income (loss) $164,746  $(733,813) $(2,799,992)
             
Net income (loss) per share - basic $0.01  $(0.06) $(0.25)
             
Net income (loss) per share - diluted $0.01  $(0.06) $(0.25)
             
Weighted average shares outstanding - basic  11,658,891   11,522,297   11,331,258 
             
Weighted average shares outstanding – diluted  11,753,669   11,522,297   11,331,258 

See notes to consolidated financial statements

27


PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC. AND SUBSIDIARIES


        Preferred Stock   Preferred Stock   Capital in        Total 
  Common Stock  (Series A)   (Series B)   excess of     Treasury  Shareholders’ 
  Shares  Amount  Shares   Amount  Shares    Amount  par value  Deficit  Stock  Equity 
Balance, January 1, 2007  7,882,074  $78,820   500  $500,000   2,082  $2,082,000  $11,926,815  $(9,335,982) $(14,950) $5,236,703 
                                         
401K contribution  124,133   1,241               165,453         166,694 
                                         
Dividend on preferred stock  134,612   1,346               236,821   (238,167)      
                                         
Common stock issued on conversion of Series A Preferred stock  500,000   5,000   (500)  (500,000)        495,000         --- 
                                         
Common stock issued on exercise of options  651,100   6,511               438,736         445,247 
                                         
Stock-based compensation expense                    34,074         34,074 
                                         
Common stock issued on conversion of Series B Preferred Stock  812,800   8,128         (2,032)  (2,032,000)  2,023,872          
                                         
Redemption of Series B Preferred Stock              (50)  (50,000)  ---         (50,000)
                                         
Net income for the year                       1,880,081      1,880,081 
                                         
Balance, December 31, 2007  10,104,719   101,046               15,320,771   (7,694,068)  (14,950)  7,712,799 
                                         
401K contribution  75,907   759               159,422         160,181 
                                         
Common stock issued on exercise of options  185,100   1,851               254,919         256,770 
                                         
Common stock issued on conversion of warrants  864,952   8,650               798,937         807,587 
                                         
Stock-based compensation expense                    88,417         88,417 
                                         
Net income for the year                       1,098,421      1,098,421 
                                         
Balance, December 31, 2008  11,230,678   112,306               16,622,466   (6,595,647)  (14,950)  10,124,175 
                                         
401K contribution  66,469   664               178,404         179,068 
                                         
Common stock issued on exercise of options  84,500   845               95,730         96,575 
                                         
Common stock issued on conversion of warrants  50,000   500               67,000         67,500 
                                         
Common stock issued on vesting of stock grants  11,700   118               (2,679)        (2,561)
                                         
Stock-based compensation expense                    112,950         112,950 
                                         
Net loss for the year                       (2,799,992)     (2,799,992)
                                         
Balance, December 31, 2009  11,443,347  $114,433     $     $  $17,073,871  $(9,395,639) $(14,950) $7,777,715 

        Capital in        Total 
  Common Stock  excess of  Accumulated  Treasury  Shareholders’ 
  Shares  Amount  par value  Deficit  Stock  Equity 
Balance, January 1, 2009  11,230,678  $112,306  $16,622,466  $(6,595,647) $(14,950) $10,124,175 
                         
401K contribution  66,469   664   178,404         179,068 
                         
Common stock issued on exercise of options  84,500   845   95,730         96,575 
                         
Common stock issued on conversion of warrants  50,000   500   67,000         67,500 
                         
Common stock issued on vesting of stock grants  11,700   118   (2,679)        (2,561)
                         
Stock-based compensation expense        112,950         112,950 
                         
Net loss for the year           (2,799,992)     (2,799,992)
                         
Balance, December 31, 2009  11,443,347   114,433   17,073,871   (9,395,639)  (14,950)  7,777,715 
                         
401K contribution  103,403   1,034   153,501         154,535 
                         
Common stock issued on exercise of options  10,000   100   8,400         8,500 
                         
Common stock issued on vesting of stock grants  5,906   59   (1,298)        (1,239)
                         
Stock-based compensation expense        168,054         168,054 
                         
Net loss for the year           (733,813)     (733,813)
                         
Balance, December 31, 2010  11,562,656   115,626   17,402,528   (10,129,452)  (14,950)  7,373,752 
                         
401K contribution  124,669   1,249   128,749         129,998 
                         
Common stock issued on exercise of options  20,000   200   18,800         19,000 
                         
Common stock issued on vesting of stock grants  6,239   62   (802)        (740)
                         
Stock-based compensation expense        171,239         171,239 
                         
Net income for the year           164,746      164,746 
                         
Balance, December 31, 2011  11,713,564  $117,137  $17,720,514  $(9,964,706) $(14,950) $7,857,995 

See notes to consolidated financial statements

28

PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC AND SUBSIDIARIES


  Years Ended December 31, 
  2009  2008  2007 
Cash flows from operating activities:         
Net (loss) income $(2,799,992) $1,098,421  $1,880,081 
             
Adjustments to reconcile net (loss) income to net cash provided by operating activities:            
Depreciation and amortization  1,008,310   1,059,741   1,119,887 
Goodwill impairment charge  1,558,074       
401K common stock contribution  179,068   160,180   166,694 
Deferred income taxes     (408,000)   
Gain on sale of plant and equipment  (4,671)  (9,113   
(Gain) loss on sale of precious metal  (7,371)     5,851 
Stock-based compensation expense  112,950   88,417   34,074 
Change in inventory reserve  94,628   302,511   163,391 
             
Changes in operating assets and liabilities:            
Accounts receivable  882,930   (628,743)  214,627 
Inventories  371,735   (103,767)  (758,438)
Other current assets  24,003   (24,019)  12,522 
Other assets  34,107   7,865   32,854 
Accounts payable and accrued liabilities  (528,015)  (581,301  246,568 
Customer advances  (110,325)  (413,796)  (117,413
Total adjustments  3,615,423   (550,025  1,120,617 
Net cash provided by operating activities  815,431   548,396   3,000,698 
             
Cash flows from investing activities:            
Proceeds (purchase) of certificates of deposit  800,000   (800,000)   
Purchase of plant and equipment  (210,563)  (784,534)  (246,518)
Purchase of precious metals  (53,538)      
Proceeds from sale of plant and equipment  4,671   10,000    
        Proceeds from sale of precious metals  16,317      12,030 
Net cash provided by (used in) investing activities  556,887   (1,574,534)  (234,488)
             
Cash flows from financing activities:            
Net proceeds from issuance of common stock  161,514   1,064,357   445,247 
Redemption of Series B Preferred shares        (50,000
Principal payments of notes payable-other  (136,609)  (14,989)  (647,215)
Principal payments of convertible promissory notes     (1,700,000  (1,000,000
Principal payments of capital lease obligations     (47,088)  (196,349)
 
             Net cash provided by (used in) financing activities
  24,905   (697,720)  (1,448,317
             
Net increase (decrease) in cash and cash equivalents  1,397,223   (1,723,859  1,317,893 
             
Cash and cash equivalents at beginning of the year  2,672,087   4,395,945   3,078,052 
             
Cash and cash equivalents at end of the year $4,069,310  $2,672,087  $4,395,945 
             
Supplemental Disclosure of Cash Flow Information:            
Interest paid $19,000  $508,000  $298,000 
Income taxes (refund) paid $(8,000) $408,000  $69,000 

  Years Ended December 31, 
  2011  2010  2009 
Cash flows from operating activities:            
             
Net income (loss) $164,746  $(733,813) $(2,799,992)
             
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:            
Depreciation and amortization  835,788   941,941   1,008,310 
Goodwill impairment charge        1,558,074 
401K common stock contribution  129,998   154,535   179,068 
Accrued interest on Related Party Convertible Note Payable     150,000   150,000 
Loss (gain) on sale of plant and equipment  1,003      (4,671)
(Gain) on sale of precious metals        (7,371)
Stock-based compensation expense  171,239   168,054   112,950 
Change in inventory reserve  55,174   (154,326)  94,628 
             
Changes in operating assets and liabilities:            
Accounts receivable  171,705   (296,920)  882,930 
Inventories  (573,818)  29,423   371,735 
Other current assets  (66,055)  44,838   24,003 
Other assets  10,679   (2,043)  34,107 
Accounts payable and accrued liabilities  41,567   178,540   (678,015)
Customer advances  (175,169)  95,558   (110,325)
Accrued interest on Related Party Convertible Note Payable  (1,125,000)      
Total adjustments  (522,889)  1,309,600   3,615,423 
Net cash (used in) provided by operating activities  (358,143)  575,787   815,431 
             
Cash flows from investing activities:            
Proceeds from sale of certificates of deposit        800,000 
Purchase of plant and equipment  (303,999)  (278,241)  (210,563)
Purchase of precious metals  (317,517)     (53,538)
Proceeds from disposal of plant and equipment  6,000      4,671 
Proceeds from disposal of precious metals        16,317 
Net cash (used in) provided by investing activities  (615,516)  (278,241)  556,887 
             
Cash flows from financing activities:            
Net proceeds from issuance of common stock  18,260   7,261   161,514 
Principal payments of notes payable-other  (9,441)  (9,072)  (136,609)
Net cash provided by (used in) financing activities  8,819   (1,811)  24,905 
             
Net (decrease) increase in cash and cash equivalents  (964,840)  295,735   1,397,223 
             
Cash and cash equivalents at beginning of the year  4,365,045   4,069,310   2,672,087 
             
Cash and cash equivalents at end of the year $3,400,205  $4,365,045  $4,069,310 
             
Supplemental Disclosure of Cash Flow Information:            
Interest paid $1,289,000  $14,000  $19,000 
Income taxes (refund) paid $18,000  $(74,000) $(8,000)

See notes to consolidated financial statements

29


PHOTONIC PRODUCTS GROUP,

INRAD OPTICS, INC. AND SUBSIDIARIES



THREE YEARS ENDED DECEMBER 31, 2009

1.Nature of Business and Summary of Significant Accounting Policies and Estimates
2011

1.Nature of Business and Operations and Summary of Significant Accounting Policies and Estimates

a.Nature of Business and Operations
Photonic Products Group,

Inrad Optics, Inc. and Subsidiaries (the “Company”), formerly known as Photonic Products Group, Inc., was incorporated in the state of New Jersey and is a manufacturer of crystals, crystal devices, electro-optic and optical components, and sophisticated laser subsystems and instruments. The Company’sCompany has manufacturing operations in Northvale, New Jersey and Sarasota, Florida. Its principal customers include commercial instrumentation companies and OEM laser manufacturers, research laboratories, government agencies, and defense contractors. The Company’s products are sold domestically using its own sales staff, and in major overseas markets, principally Europe and the Far East,Japan, and Asia, using independent sales agents.

b.  b.Principles of consolidation

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Upon consolidation, all inter-company accounts and transactions are eliminated.

c.  c.Use of estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from these estimates.

d.  d.Cash and cash equivalents

The Company considers cash-on-hand and highly liquid investments with original maturity dates of three months or less at the date of purchase to be cash and cash equivalents. Investments with original maturity dates exceeding three months are separately disclosed on the Consolidated Balance Sheets and as cash flows from investing activities on the Consolidated Statements of Cash Flows.

e.  e.Accounts receivable

Accounts receivable are carried at net realizable value, net of write-offs and allowances. The Company establishes an allowance for doubtful accounts based on estimates as to the collectibilitycollectability of accounts receivable. Management specifically analyzes past-due accounts receivable balances and, additionally, considers bad debt history, customer credit-worthiness, current economic trends and changes in customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. Uncollectible accounts receivable are written-off when it is determined that the balance will not be collected.

f.  f.Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or market. Cost of manufactured goods includes material, labor and overhead.

The Company records a reserve for slow moving inventory as a charge against earnings for all products identified as surplus, slow moving or discontinued. Excess work-in-process costs are charged against earnings whenever estimated costs-of-completion exceed unbilled revenues.

g.  g.Plant and Equipment

Plant and equipment are depreciated using the straight-line method over the estimated useful lives of the related assets which range between 5 and 7 years. Amortization of leasehold improvements is computed using the straight-line method over the lesser of 10 years or the remaining term of the lease including optional renewal periods, as appropriate, when failure to renew the lease imposes an economic penalty on the Company in such an amount that renewal appears to be probable, as that term is defined in paragraph 840-10-20 of the FASB Accounting Standards Codification.probable. In determining the amount of the economic penalty, management considers such factors as (i) the costs associated with the physical relocation of the offices, manufacturing facility and equipment, (ii) the economic risks associated with business interruption and potential customer loss during relocation and transition to new premises (iii) the significant costs of leasehold improvements required at any new location to custom fit our specific manufacturing requirements, and (iv) the economic loss associated with abandonment of existing leasehold improvements or other assets whose value would be impaired by vacating the facility.

30

Maintenance and repairs of property and equipment are charged to operations and major improvements are capitalized. Upon retirement, sale or other disposition of property and equipment, the cost and accumulated depreciation are eliminated from the accounts and a gain or loss is recorded.

h.  h.Income taxes
The Company accounts for income taxes under FASB ASC 740, Income Taxes (“ASC 740”).

Deferred taxes are provided on the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

The Company recognizes the financial statement benefit of an uncertain tax position only after determining that the relevant tax authority would more likely than not sustain the position. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company adopted the provisions of the current accounting guidance on January 1, 2007, as a result of which, the Company did not recognize a material adjustment to the liability for unrecognized income tax benefits.


The Company classifies interest and penalties related to income taxes as income tax expense in its Consolidated Financial Statements.

The Company had no unrecognized tax benefits or liabilities, and no adjustment to its financial position, results of operations, or cash flows relating to uncertain tax positions taken on all open tax years. The Company is no longer subject to federal, state or local income tax examinations by tax authorities for the years before 2008.

i.  i.Impairment of long-lived assets

Long-lived assets, such as property, plant and equipment and purchased intangibles with finite lives, which are subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimateestimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Long-lived assets held for sale would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and would no longer be depreciated.

j.  j.Goodwill and intangible assets with indefinite lives

Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable assets of business acquisitions. Goodwill and intangible assets with indefinite lives are not amortized. The Company tests for impairment of goodwill and intangible assets with indefinite lives on an annual basis in December of each year, or more frequently whenever events occur or circumstances exist that indicates that impairment may exist.

k.  k.Stock-based compensation

Stock based compensation expense is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value of restricted stock units granted is estimated based on the closing market price of the Company’s common stock on the date of the grant. The fair value of these awards, adjusted for estimated forfeitures, is amortized over the requisite service period of the award, which is generally the vesting period.

l.  l.Revenue recognition

The Company records revenue from the sale of products and services used in the photonics industry when all four of the following criteria are met:

·persuasive evidence of an arrangement exists;

·delivery has occurred or services have been rendered;

·the sales price is fixed or determinable; and

·  collectability·Collectability is reasonably assured.

Losses on contracts in progress are recorded when identified.

m.  m.Internal research and development costs

Internal research and development costs are charged to expense as incurred.

31

n.  n.Precious metals

Precious metals consist of various fixtures used in the high temperature crystal growth manufacturing process. They are valued at the lower of cost or net realizable value, on a first-in, first-out basis.

value.

o.  o.Advertising costs

Advertising costs included in selling, general and administrative expenses were $32,000, $26,000$16,000, $29,000 and $29,000$32,000 for the years ended December 31, 2009, 20082011, 2010 and 2007,2009, respectively. Advertising costs are charged to expense when the related services are incurred or related events take place.

p.           Statement of cash flows and non-cash transactions

p.Statement of cash flows and non-cash transactions

For purposes of the consolidated statements of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months, or less when purchased, to be cash equivalents.

In 2007, non-cash financing transactions resulting from the exchange of Series A convertible preferred stock in exchange for common shares amounted to $500,000 and the exchange of Series B convertible preferred stock for common stock amounted to $2,032,000.
q.           Concentrations and credit risk

q.Concentrations and credit risk

The Company may invest its excess cash in certificates of deposits with major financial institutions. Generally, the investments range over a variety of maturity dates usually, within three to nine months, and therefore, are subject to little risk. The Company has not experienced losses related to these investments.

The concentration of credit risk in the Company’s accounts receivable is mitigated by the Company’s credit evaluation process, familiarity with its small base of recurring customers and reasonably short collection terms and the geographical dispersion of revenue. The Company generally does not require collateral but, in some cases, the Company negotiates cash advances prior to the undertaking of the work. These cash advances are recorded as current liabilities on the balance sheet until corresponding revenues are realized.

The Company utilizes many relatively uncommon materials and compounds to manufacture its products and relies on outside vendors for certain manufacturing services. Therefore, any failure by its suppliers to deliver materials of an adequate quality and quantity could have an adverse effect on the Company’s ability to meet the commitments of its customers.

For the year ended December 31, 2009,2011, the Company’s top five customer accounts in the aggregate represented approximately 52%58% of total revenues, and the top three customers accounted for 41%47% of revenues. These three customers each represented approximately 18%21%, 14%15% and 10%11% of sales, respectively. Since the Company is a supplier of custom manufactured components to OEM customers, the relative size and identity of the largest customer accounts changes somewhat from year to year. In the short term, the loss of any one of these large customer accounts could have a material adverse effect on business, results of operations, and financial condition.

r.           Fair value measurements
Effective January 1, 2008, the

r.Fair value measurements

The Company adopted newfollows U.S. GAAP accounting guidance for all financial assets and liabilities and for non-financial assets and liabilities that are recognized or disclosed in the financial statements at fair value on a recurring basis. Additionally, effective January 1, 2009, the Company adopted new accounting guidance for non-financial assets and liabilities that are recognized or disclosed in the financial statements at fair value on a non-recurring basis. Although such adoption did not have a material impact on the Company’s Consolidated Financial Statements for 2009 or 2008, the pronouncement may impact the Company’s accounting for future business combinations, impairment charges and restructuring charges.

This new accounting guidance establishedwhich establishes a framework for measuring fair value and expanded related disclosures. The framework requires fair value to be determined based on the exchange price that would be received for an asset, or paid to transfer a liability (an exit price), in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants.

The valuation techniques required are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. The accounting guidance requires the following fair value hierarchy:

·Level 1 - Quoted prices (unadjusted) for identical assets and liabilities in active markets that the Company has the ability to access at the measurement date.

32


·Level 2 - Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from or corroborated by observable market data through correlation.

·Level 3 - Values determined by models, significant inputs to which are unobservable and are primarily based on internally derived assumptions regarding the timing and amount of expected cash flows.

Long-lived assets, including goodwill and other intangible assets, may be measured at fair value if such assets are held for sale or if there is a determination that the asset is impaired. Managements’ determination of fair value, although highly subjective, is based on the best information available, including internal projections of future earnings and cash flows discounted at an appropriate interest rate, quoted market prices when available, market prices for similar assets, broker quotes and independent appraisals, as appropriate.

s.New Accounting Guidance

In May 2009, the FASB issued new guidance on management’s assessment of subsequent events, which establishes the accounting and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. It required the disclosure of the date through which an entity evaluated subsequent events and the basis for that date. In February 2010, the FASB issued an update to this guidance which requires that SEC filers evaluate subsequent events through the date financial statements are available to be issued, but removed the requirement to disclose that date.  The updated guidance was effective upon issuance, and did not have a material impact on the Company’s consolidated financial statements

In October 2009,2011, the Financial Accounting Standards Board (“FASB”) issued accounting guidanceAccounting Standards Update (“ASU”) No. 2011-04, “Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards (“IFRS”).” This pronouncement was issued to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and IFRS. ASU 2011-04 changes certain fair value measurement principles and enhances the accounting modeldisclosure requirements particularly for revenue arrangements that include both tangible products and software elements that function together to deliver the product’s essential functionality.  The accounting guidance more closely reflects the underlying economics of these transactions.  The Company is evaluating the impact of adopting this guidance whichLevel 3 fair value measurements. This pronouncement is effective for reporting periods beginning on January 1, 2011.
In October 2009, the FASB issued accounting guidance that sets forth the requirements that must be met for a company to recognize revenue from the sale of a delivered item that is part of a multiple-element arrangement when other items have not yet been delivered.or after December 15, 2011, with early adoption prohibited. The new guidance will berequire prospective application. The Company expects that the adoption will not have a significant impact on its Consolidated Financial Statements.

In June 2011, the FASB issued ASU No. 2011-05, “Presentation of Comprehensive Income” which was issued to enhance comparability between entities that report under U.S. GAAP and IFRS, and to provide a more consistent method of presenting non-owner transactions that affect an entity’s equity. ASU 2011-05 eliminates the option to report other comprehensive income and its components in the statement of changes in stockholders’ equity and requires an entity to present the total of comprehensive income, the components of net income and the components of other comprehensive income either in a single continuous statement or in two separate but consecutive statements. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and full retrospective application is required. The Company expects that the Company prospectivelyadoption will not have a significant impact on its Consolidated Financial Statements.

In September 2011, the FASB issued Accounting Standards Update (“ASU”) No. 2011-08, Intangibles-Goodwill and Other – Testing Goodwill for revenue arrangements entered into or materially modified on orImpairment (“ASU No. 2011-08”). ASU No. 2011-08 permits an entity to make a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before automatically applying the two-step goodwill impairment test, which has been the required test since 2002. If an entity determines that this is the case, it is necessary to perform the currently prescribed two-step goodwill impairment test to determine the amount, if any, of impaired goodwill. Otherwise, the two-step goodwill impairment test is not required. This new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after January 1, 2011.  EarlyDecember 15, 2011 with early adoption of this standard is permitted. The Company is still assessinghas not elected early adoption and expects that the potential impactadoption of adopting thisthe new guidance.

In August 2009, the FASB issued accounting guidance which provides clarification that, in the absence of a quoted price for a liability, companies may apply methods that use the quoted price of an investment traded as an asset or other valuation techniques consistent with the fair-value measurement principle.  The Company doesstandard will not expect this accounting guidance, which is effective for us beginning October 1, 2009, to have a materialsignificant impact on its consolidated financial position, results of operations or cash flows.
In June 2009, the FASB issued authoritative guidance to establish the FASB Accounting Standards Codification (the “Codification”) as the source of authoritative accounting principles and the framework for selecting the principles used in the preparation of financial statements of non-governmental entities that are presented in conformity with generally accepted accounting principles in the United States.  The Codification, which changes the referencing of financial standards, supersedes current authoritative guidance and is effective for interim or annual financial periods ending after September 15, 2009. The Codification is not intended to change or alter existing GAAP and it is not expected to result in a change in accounting practice for the Company. The Company has updated its references to reflect the Codification.
In April 2009, the FASB issued additional accounting guidance for other-than-temporary impairments to improve the consistency in the timing of impairment recognition, as well as provide greater clarity to investors about credit and non-credit components of impaired debt securities that are not expected to be sold.  The adoption of this accounting guidance did not have a material impact on our consolidated financial position, results of operations or cash flows.
In April 2009, the FASB issued accounting guidance which primarily addresses the measurement of fair value of financial assets and liabilities when there is no active market or where the price inputs being used could be indicative of distressed sales.  The adoption of this accounting guidance did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
2.Inventories, net
Consolidated Financial Statements.

2.Inventories, net

Inventories are comprised of the following and are shown net of inventory reserves of $1,410,000$1,310,000 for 20092011 and $1,315,000$1,255,000 for 2008:

33


  December 31, 
  2009  2008 
  (In thousands) 
Raw materials $1,066  $1,169 
Work in process, including manufactured parts and components  654   1,117 
Finished goods  546   446 
  $2,266  $2,732 
3.Property and Equipment
Property2010:

  December 31, 
  2011  2010 
  (In thousands) 
Raw materials $1,072  $1,103 
Work in process, including manufactured parts and components  984   806 
Finished goods  854   482 
  $2,910  $2,391 

3.Plant and Equipment

Plant and equipment are comprised of the following:


  December 31, 
  2009  2008 
  (In thousands) 
Office and computer equipment $1,330  $1,274 
Machinery and equipment  11,230   11,127 
Leasehold improvements  2,044   2,044 
   14,604   14,445 
Less accumulated depreciation and amortization  (12,016)  (11,140)
  $2,588  $3,305 

  December 31, 
  2011  2010 
  (In thousands) 
Office and computer equipment $1,461  $1,339 
Machinery and equipment  11,514   11,436 
Leasehold improvements  2,197   2,104 
   15,172   14,879 
Less accumulated depreciation and amortization  (13,629)  (12,876)
  $1,543  $2,003 

Depreciation expense (including amortization expense on software) recorded by the Company totaled $1,006,000, $1,060,000$757,000, $863,000 and $1,120,000$929,000 for 2011, 2010 and 2009, 2008respectively. Plant and 2007,equipment with a net book value of $7,003, $944 and $0 was disposed of in 2011, 2010 and 2009, respectively.

4.Goodwill

The following table summarizes goodwill balancesCompany evaluates its property and equipment and intangible assets with finite lives for impairment when events or circumstances indicate and impairment may exist. Management concluded that an impairment of its long-lived assets was not required at December 31, 20092011 and 2008 and changes in theDecember 31, 2010.

4.Goodwill

The carrying amountvalue of goodwill during the year endedwas $312,000 at December 31, 2009:    

    
Amount 
 (in thousands)
 
Balance at December 31, 2008  $1,870 
Impairment charge   (1,558)
Balance at December 31, 2009
 
`
 $312 
During 2009, the2011 and 2010.

The Company experienced declines in sales and profitability, and economic and industry conditions remained uncertain.  As a result, the Company testedtests for impairment of goodwill for its two reporting units which the Company has identified as its two geographical operating units in Florida and New Jersey. In making this assessment, management considered a numberDecember of factors which include, among others, historical and current operating results and cash flows, current projections of future financial results and cash flows, business plans, current and projected economic conditions and industry trends.  There are inherent uncertainties associated with these factors and significant judgment is involved in evaluating each.

each year. The testing for goodwill impairment is a two-step process. The first step compares the fair value of each reporting unit to its carrying value. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired as of the measurement date. Otherwise, if the carrying value exceeds the fair value, a second step must be followed to determine the level of impairment. In establishing the fair value of the reporting unit, the Company uses both a market based approach and an income based approach as part of its valuation methodology. Since quoted market prices in an active market are not separately available for the Company’s reporting units, the market based method estimates the fair value of the reporting unit utilizing an industry multiple of projected earnings before interest taxes, depreciation and amortization (“EBITDA”). Due to the small capitalization value of the Company, the low trading volume of its stock and the niche market served by its products, the application of available industry comparables in establishing fair value requires a high degree of management judgment, and the actual fair value that could be realized could differ from those used to evaluate the impairment of goodwill. The income approach determines fair value based on the estimated discounted cash flows that each reporting unit is expected to generate in the future. For each method, the sensitivity of key assumptions are tested by using a range of estimates and the results of each method are corroborated as part of management’s determination of fair value.

The second step of the testing process, if necessary, involves calculating the fair value of the individual assets and liabilities of the reporting unit and measuring the implied fair value of the goodwill against its carrying value to determine whether an adjustment to the carrying value of goodwill is required. This process also has inherent risks and uncertainties and requires significant management judgment.

Upon completion of the first step, the Company concluded that the carrying value of its Florida reporting unit exceeded its fair value and a step two analysis was required.  The step-two analysis resulted in the Company recording an impairment charge against the full carrying value of goodwill of its Florida reporting unit, in the amount of $1,558,000. The Company has determined that the carrying value of its goodwill in connection with its acquisitions of its New Jersey reporting unit in the amount of $312,000 is not impaired as of December 31, 2009.
34

The Company also evaluated its property and equipment and intangible assets for impairment.  

Based on the results of the tests performed, management concluded that that anthere is no impairment of its long-lived assets is not requiredgoodwill at December 31, 2009.

5.Intangible Assets
2011.

5.Intangible Assets

Intangible assets include acquired intangible assets with finite lives, consisting principally of non-contractual customer relationships, completed technology and trademarks. Intangible assets with finite lives are amortized on a straight-line basis over the assets’ estimated useful life up to 14 years. The Company evaluates whether events or circumstances have occurred indicating the carrying amount of intangible assets may not be recoverable. When factors indicate that intangible assets should be evaluated for possible impairment, the Company uses an estimate of the associated undiscounted future cash flows compared to the related carrying amount of assets to determine if an impairment loss should be recognized. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value.

The gross carrying amount of intangible assets as of December 31, 2009 and 2008 was $1,100,000, respectively.  Accumulated amortization related to intangible assets was $427,000 as of December 31, 2009 and $348,000 as of December 31, 2008.  

Amortization expense was approximately $79,000 for the years ended December 31, 20092011 and December 31, 2008,2010, respectively. Aggregate amortization for the five succeeding years from January 1, 20102012 through December 31, 20142016 is expected to be approximately $395,000, accumulating at the rate of $79,000 per year. The weighted average remaining life of the Company’s intangible assets is approximately 8.56.5 years.

The following schedule details the Company’s intangible asset balance by major asset class.


  At December 31, 2009 
   
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net Carrying
Amount
 
  (In thousands)
Customer-related $550  $(213) $337 
Completed technology  363   (141)  222 
Trademarks  187   (73)  114 
             
Total $1,100  $(427) $673 

  At December 31, 2008 
  
Gross Carrying
Amount
  
Accumulated
Amortization
  
Net Carrying
Amount
 
  (In thousands) 
Customer-related $550  $(174) $376 
Completed technology  363   (115)  248 
Trademarks  187   (59)  128 
             
Total $1,100  $(348) $752 
6.         Related Party Transactions

  At December 31, 2011 
  Gross Carrying 
Amount
  Accumulated
Amortization
  Net Carrying 
Amount
 
  (In thousands) 
Customer-related $550  $(292) $258 
Completed technology  363   (193)  170 
Trademarks  187   (99)  88 
             
Total $1,100  $(584) $516 
  At December 31, 2010 
  Gross Carrying 
Amount
  Accumulated
Amortization
  Net Carrying 
Amount
 
  (In thousands) 
Customer-related $550  $(252) $298 
Completed technology  363   (167)  196 
Trademarks  187   (87)  100 
             
Total $1,100  $(506) $594 

6.Related Party Transactions

In March 2009,2011, the maturity datedates of a $1,500,000 Subordinated Convertible Promissory Note to Clarex Limited (“Clarex”) wasand a $1,000,000 Subordinated Convertible Promissory Note to an affiliate of Clarex were extended to April 1, 2013. The remaining terms and conditions of the notes were unchanged. These notes were previously issued on April 1, 2009 and had a maturity date of April 1, 2011. The note bearsnotes bear interest at 6% and was originally due in January 2006, extended to December 31, 2008 and subsequently extended again to April 1, 2009.. Interest accrues yearly, is payable on maturity and unpaid interest along with principal may be converted into securities of the Company as follows: The Note isnotes are convertible in the aggregate into 1,500,000 Units and 1,000,000 Units, respectively, with each unit consisting of one share of common stock and one warrant. The warrants had an original expiration date of August 2009 and eachEach warrant allowedallows the holder to acquire 0.75 shares of common stock at a price of $1.35 per share.  Theshare and have an expiration date of the warrants under the conversion terms has been extended to April 1, 2014.2, 2016. Clarex is a majorsignificant shareholder of the Company.

During 2011, the Company paid the accrued interest of $645,000 and debt holder.

$480,000 on the $1,500,000 Note and the $1,000,000 Note, respectively that was outstanding as of December 31, 2010. In March 2009,addition, the Company prepaid $150,000 for the interest that currently accrued on the Notes in 2011. The Company expects to continue to prepay its currently accruing quarterly interest obligations on the Notes of $37,500 per quarter through the maturity date

7.Notes Payable – Other

Notes payable - Other consist of a $1,000,000 Subordinated Convertible Promissory Note bearing interest at 6% was extended to April 1, 2011.  The note was originally due in January 2006 and was subsequently extended to April 1, 2009.  Interest accrues yearly and along with principal may be converted into securities of the Company as follows:  The Note is convertible in the aggregate into 1,000,000 Units with each unit consisting of one share of common stock and one warrant.  The warrants had an original expiration date of August 2009 and each warrant allowed the holder to acquire 0.75 shares of common stock at a price of $1.35 per share.  The expiration date of the warrants under the conversion terms has been extended to April 1, 2014.  The holder of the note is an affiliate of Clarex.

35

Both these extensions of Subordinated Convertible Promissory Notes had no impact on the Company’s financial statements.
In May, 2008, Clarex exercised 200,000 warrants set to expire on May 18, 2008 for $216,000 and the Company issued 200,000 shares of its common stock.
In March, 2008, Clarex elected to exercise the 200,000 warrants expiring on March 31, 2008 and the Company issued 200,000 shares of its commons stock for proceeds of $85,000.
In January 2008, the Company repaid in full a $1,700,000 Secured Promissory Note held by Clarex, including accrued interest of $477,444.
7.Notes Payable - Other
 The remaining $125,000 balance of a $175,000 Note originally issued as part of the purchase of MRC on October 16, 2004, to the sole shareholder, along with accrued interest of $4,212 was paid in May 2009, prior to the maturity date.  Three additional notes, totaling $295,725, were assumed from note holders of MRC subsequent to its acquisition.  The notes had interest rates ranging from 6.0% to 10.5% and were payable from 2 to 4 years.  In 2005, two of the notes totaling $199,525 were exchanged for two notes totaling $125,000, 80,000 shares of common stock of the Company and 60,000 warrants exercisable for 60,000 shares of common stock at $1.35 per share.  The warrants expire in 2010.  Two of the three additional notes were paid in full in 2006 and the remaining note was paid in May 2009. In addition, a noteamounts payable to the U.S. Small Business Administration was also assumed by the Company.  The remaining  note has a balance of $353,946 as of December 31, 2009, bears interest at the rate of 4.0% and is due in 2032.
Administration.

  December 31, 
  2011  2010 
  (rounded to the nearest 000’s) 
Notes payable - Other, payable in aggregate monthly installments of approximately $1,925 and bearing an interest rate of 4.0% and expiring in April 2032 $335,000  $345,000 
Less current portion  (10,000)  (9,000)
Notes payable - Other, excluding current portion $325,000  $336,000 

Notes payable - Other, consist of the following:


  December 31, 
  2009  2008 
    
Notes payable - Other, payable in monthly installments of approximately $1,925, and bearing an interest rate of 4.0% and expiring in April 2032. $354,000  $491,000 
Less current portion  (9,000)  (137,000)
Long-term debt, excluding current portion $345,000  $354,000 
Notes payable other, mature as follows:

Year ending December 31: 
2010 $9,000 
2011  9,400 
2012  9,800 
2013  10,200 
2014  10,600 
Thereafter  305,000 
  $354,000 

36

8.Accounts Payable and Accrued Expenses

 Year ending December 31: 
 2011  $9,800 
 2012   10,200 
 2013   10,600 
 2014   11,100 
 2015   11,500 
 Thereafter   281,800 
    $335,000 

8.Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses are comprised of the following:

  December 31, 
  2011  2010 
  (In thousands) 
Trade accounts payable and accrued purchases $483  $424 
Accrued vacation  85   179 
Accrued payroll  102   87 
Accrued 401K common stock contribution  152   130 
Accrued expenses – other  56   16 
  $878  $836 

33

  December 31, 
  2009  2008 
  (in thousands) 
Trade accounts payable and accrued purchases $328  $575 
Accrued vacation  205   389 
Accrued payroll  63   150 
Accrued interest  975   827 
Accrued payroll tax payable  8   9 
Accrued bonus     81 
State and Federal income tax (prepaid) payable  (107)  (92)
Accrued 401K common stock contribution  155   172 
Accrued expenses – other  6   50 
  $1,633  $2,161 
9.Income Taxes

9.Income Taxes

The Company’s income tax benefit (provision)provision consists of the following:


  Years Ended 
  December 31, 
  2009  2008  2007 
          
Current:         
     Federal provision $  $(5,000) $(50,000)
     State provision     ( 100,000)  (200,000)
      (105,000)  (250,000)
Deferred:            
     Federal tax benefit     408,000    
     State         
      408,000    
Total $  $303,000  $(250,000)

  Years Ended 
  December 31, 
  2011  2010  2009 
          
Current:            
    Federal provision for AMT $6,000  $  $ 
    State provision  5,000       
   11,000       
Deferred:            
    Federal tax benefit         
    State         
          
Total $11,000  $  $ 

A reconciliation of the income tax provision computed at the statutory Federal income tax rate to our effective income tax rate follows (in percent):


  Year s Ended 
  December 31, 
  2009  2008  2007 
Federal statutory rate  (34.0) %  34.0%  34.0%
State statutory rate  ( 8.0)  12.6   9.4 
Net operating loss carryforward - Federal     (34.0)  (34.0)
Federal AMT     0.6   2.3 
Expected tax benefit of net operating loss carryforward     (51.3)   
Goodwill impairment charge  22.0       
Change in Valuation Allowance  25.6       
Prior year adjustments  ( 5.6)      
Effective income tax rate  %  (38.1) %  11.7%
37

  Years Ended 
  December 31, 
  2011  2010  2009 
Federal statutory rate  34.0%  (34.0)%  (34.0)%
State statutory rate  8.0   (7.4)  (6.5)
Goodwill impairment charge        22.0 
Change in Valuation Allowance  (41.5)  37.0   13.4 
Permanent Differences  6.7       
Prior year adjustments     4.4   5.1 
Other  0.9       
Effective income tax rate  6.3%  %  %

At December 31, 2009,2011, the Company has estimated Federal and State net operating loss carry forwards of approximately $5,824,000$5,716,000 and $1,406,000,$1,164,000, respectively. These tax loss carry forwards expire at various dates through 2029.

2031.

Internal Revenue Code Section 382 places a limitation on the utilization of Federal net operating loss and other credit carry forwards when an ownership change, as defined by the tax law, occurs. Generally, this occurs when a greater than 50 percentage point change in ownership occurs. Accordingly, the actual utilization of the net operating loss and carryforwards for tax purposes may be limited annually to a percentage (approximately 6%)(based on the risk free interest rate) of the fair market value of the Company at the time of any such ownership change. The Company has not prepared an analysis of ownership changes but does not believe that a greater than 50% change of ownership has occurred and such limitations would not apply to the Company.

Deferred tax assets (liabilities) are comprised of the following:

  December 31, 
  2009  2008 
       
Inventory reserves $593,000  $410,000 
Accrued vacation  86,000   133,000 
Account receivable reserves  6,000    
Depreciation  86,000   (280,000)
Loss carry forwards  2,086,000   1,878,000 
Gross deferred tax assets  2,857,000   2,141,000 
Valuation allowance  (2,449,000)  (1,733,000)
Net deferred tax asset $408,000  $408,000 

  December 31, 
  2011  2010 
       
Account receivable reserves $7,000  $7,000 
Inventory reserves  551,000   528,000 
Inventory capitalization  178,000   154,000 
Accrued vacation  36,000   76,000 
Depreciation  76,000   (154,000)
Loss carry forwards  2,012,000   2,176,000 
Gross deferred tax assets  2,860,000   2,787,000 
Valuation allowance  (2,452,000)  (2,379,000)
Net deferred tax asset $408,000  $408,000 
         

In evaluating the Company’s ability to recover deferred tax assets in future periods, management considers the available positive and negative factors, including the Company’s recent operating results, the existence of cumulative losses and near term forecasts of future taxable income that is consistent with the plans and estimates management is using to manage the underlying business. As of December 31, 20092011 and 2008,2010, the Company has recognized a deferred tax asset of $408,000 which we estimate will be recoverable in future periods, net of a valuation allowance of $2,449,000.

10.$2,452,000 and $2,379,000, respectively.

The Company files income tax returns in the United States, which typically provides for a three-year statute of limitations on assessments. However, because of net operating loss carryforwards, substantially all of our tax years remain open to federal tax examination.

The guidance for accounting for uncertainties in income taxes requires that we recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. There were no unrecognized tax benefits that impacted our effective tax rate and accordingly, there was no material effect to our financial position, results of operations or cash flows.

Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. To date, there have been no interest or penalties charged to us in relation to the underpayment of income taxes.

We do not anticipate that our unrecognized tax benefits will significantly increase in the next 12 months.

10.Equity Compensation Program and Stock-based Compensation

a.2010 Equity Compensation Program

The Company’s 2010 Equity Compensation Program and Stock-based Compensation

a.           2000 Equity Compensation Program
was approved by the shareholders of the Company at the Annual Meeting which was held on June 2, 2010. The Company’s 20002010 Equity Compensation Program provides for grants of options, stock appreciation rights and performance sharesrestricted stock awards to employees, officers, directors, and others who render services to the Company. The program consistsProgram is comprised of four plansparts including: (i) the Incentive Equity Compensation ProgramStock Option Plan which provideprovides for grants of “incentive stock options”, (ii) the Supplemental ProgramStock Option Plan which provideprovides for grants of stock options to non-employees,that shall not be “incentive stock options”, (iii) the SAR ProgramStock Appreciation Rights Plan which allows the granting of stock appreciation rights and, (iv) the Performance Share Program underRestricted Stock Award Plan which eligible participants may receive stock awards, including restricted stockprovides for the granting of restrictive shares of Common Stock and restricted stock units. The plans areplan is administered by the Compensation Committee of the Board of Directors. Under these plans,this plan, an aggregate of up to 6,000,0004,000,000 shares of common stock may be granted.

b.2000 Equity Compensation Program

The Company’s 2000 Equity Compensation Program expired on June 2, 2010. All outstanding grants of options, stock appreciation rights and performance shares issued under the Program will remain outstanding and shall expire on the date determined by the terms of the original grant. The latest date of expiration for outstanding grants under the plan expires in August 2010. The Company’s Board of Directors has approved a new plan covering 4,000,000 million shares, which is subject to shareholder approval at the Company’s next annual meeting.

b.           Stock Option Expense
March 28, 2020.

c.Stock Option Expense

The Company's results for the years ended December 31, 2009, 20082011, 2010 and 20072009 include stock-based compensation expense for stock option grants totaling $65,000, $47,000$165,000, $127,000 and $34,000,$65,000, respectively. Such amounts have been included in the Consolidated Statements of Operations within cost of goods sold ($7,00068,000 for 2009, $8,0002011, $48,000 for 20082010 and $8,000$7,000 for 2007)2009), and selling, general and administrative expenses ($58,00097,000 for 2009, $39,0002011, $79,000 for 20082010 and $26,000$58,000 for 2007)2009).

As of December 31, 2009, 20082011, 2010 and 2007,2009, there were $311,300, $17,000$382,300, $194,300 and $52,300$311,300 of unrecognized compensation costs, net of estimated forfeitures, related to non-vested stock options, which are expected to be recognized over a weighted average period of approximately 32.3 years, 1.12.3 years and 2.13.0 years, respectively.

The weighted average estimated fair value of stock options granted in the twothree years ended December 31, 2011, 2010 and 2009 was $0.86, $1.00 and 2007 was $1.22, and $1.47, respectively. The fair value of options at the date of grant was estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of our stock and other contributing factors. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The expected term is based upon the contractual term of the option.

38

The following range of weighted-average assumptions were used for to determine the fair value of stock option grants during the years ended December 31, 20092011, 2010 and 2007:


  Years Ended 
  December 31, 
  2009  2008  2007 
Dividend yield  0.00%  %  0.00%
Volatility  180 - 232%  %  144.9%
Risk-free interest rate  2.5 - 3.45%  %  4.7%
Expected life 10 years     10 years 
The Company did not issue any stock options during 2008.
c.           Stock Option Activity
The Company granted 305,084 stock options during the year ended December 31, 2009 at exercise prices ranging from $1.00 to $1.75, which was equal to the closing market price on the respective date of each grant.  The Company granted 29,039 options during the year ended December 31, 2007 at an exercise price of $1.50, which was equal to the closing market price on the date of each grant.  No stock options were granted in 2008.

2009:

  Years Ended 
  December 31, 
  2011  2010  2009 
Dividend yield      
Volatility  94 – 100
  226 - 236  180 - 232
Risk-free interest rate  2.0 - 3.4  2.7 - 3.7  2.5 - 3.45
Expected life  10 years   10 years   10 years 
d.Stock Option Activity

A summary of the Company’s outstanding stock options as of and for the years ended December 31, 2009, 20082011, 2010 and 20072009 is presented below:

 Options  
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(In Years)
 
   Aggregate Intrinsic Value(a)
 
Outstanding as of January 1, 20071,879,700  $         1.25      
Granted                                                       29,039  1.98      
Exercised                                                       (651,100) 0.68      
Forfeited /Expired                                                     (29,000) 1.98      
Outstanding as of December 31, 20071,228,639  1.52      
Granted                                                               
Exercised                                                       (182,000) 1.42      
Forfeited/Expired                                                       (16,500) 3.25      
Outstanding as of December 31, 20081,030,139  1.50      
Granted                                                       305,084  1.22      
Exercised                                                       (84,500) 1.14      
Forfeited /Expired                                                      (35,000) 1.10      
Outstanding as of December 31, 2009(b)
1,215,723 1.46 3.5  $63,295 
           
Exercisable as of December 31, 2009914,995 1.55 1.9  $63,295 

  Options  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Term
(In Years)
  Aggregate
Intrinsic
Value(a)
 
Outstanding as of January 1, 2009  1,030,139  $1.50         
Granted  305,084   1.22         
Exercised  (84,500)  1.14         
Forfeited/Expired  (35,000)  1.10         
Outstanding as of December 31, 2009  1,215,723   1.46         
Granted  10,000   1.00         
Exercised  (10,000)  .85         
Forfeited/Expired  (417,247)  2.11         
Outstanding as of December 31, 2010  798,476   1.13         
Granted  409,000   .97         
Exercised  (20,000)  .95         
Forfeited /Expired  (108,400)  1.66         
Outstanding as of December 31, 2011(b)  1,079,676  $1.02   6.7  $63,105 
                 
Exercisable as of December 31, 2011  578,086  $1.03   4.6  $63,105 

(a) Intrinsic value for purposes of this table represents the amount by which the fair value of the underlying stock, based on the respective market prices as of December 31, 20092011 exceeds the exercise prices of the respective options.


All of the options used in the calculation of the aggregate intrinsic value for outstanding options are exercisable as of December 31, 2011.

(b) Based on the Company’s historical forfeiture rate, the number of options expected to vest is the same as the total outstanding at December 31, 2009.

39

2011.

The following table represents non-vested stock options granted, vested, and forfeited for the year ended December 31, 2009.


Non-vested Options Options  Weighted-Average Grant-Date Fair Value 
Non-vested  - January 1, 2009  33,220  $1.48 
Granted  305,084  $1.22 
Vested  (37,576) $1.31 
Forfeited      
Non-vested – December 31, 2009  300,728  $1.21 
2011.

Non-vested Options Options  Weighted-Average Grant-Date
Fair Value - $
 
Non-vested  - January 1, 2011  254,525   1.14 
Granted  409,600   .86 
Vested  (157,135)  1.11 
Forfeited  (5,400)  .91 
Non-vested – December 31, 2011  501,590   .92 

The total fair value of options vested during the years ended December 31, 2011, 2010 and 2009, 2008was $175,100, $59,600 and 2007, was $49,000, $35,000 and $71,000, respectively.

The following table summarizes information about stock options outstanding at December 31, 2009:


  Options Outstanding Options Exercisable 
    Weighted       
    Average Weighted   Weighted 
    Remaining Average   Average 
Range of Number Contractual Exercise Number Exercise 
Exercise Price (1) Outstanding Life in Years Price Outstanding Price 
$0.50 - $2.00  1,143,123 9.8 $1.33 842,394 $1.37 
$3.25 - $5.00  72,600 0.8 $3.59 72,600 $3.59 
(1)   There were no outstanding options with an exercise price between $2.00 and $3.25.
d.           Restricted Stock Unit Awards
There were no grants in 2009.  2011:

  Options Outstanding  Options Exercisable 
     Weighted          
     Average  Weighted     Weighted 
     Remaining  Average     Average 
Range of Number  Contractual  Exercise  Number  Exercise 
Exercise Price Outstanding  Life in Years  Price  Outstanding  Price 
$0.50 - $1.03  912,700   6.9  $0.91   437,607  $0.84 
$1.20 - $1.75  166,976   6.0  $1.61   140,479  $1.60 

e.Restricted Stock Unit Awards

During 2008,2011, the Company granted 23,50015,000 restricted stock units under the 20002010 Performance Share Program with aan estimated fair market value of $85,300 based on the closing market price of the Company’s stock on the grant date.  In December 2007, the Company granted 12,000 restricted stock units to one individual under the 2000 Performance Share Program with a fair market value of $48,000$14,550 based on the closing market price of the Company’s stock on the grant date. These grants vest over a three year period contingent on continued employment over the vesting period. There were no previous grants of restricted stock units under this plan.  The Company recognized related stock compensation expense of $7,000 ($0 in Cost of Goods Sold and $7,000 in Selling, General and Administrative expenses) in 2011, $41,000 ($5,000 in Cost of Goods Sold and $36,000 in Selling, General and Administrative expenses) in 2010 and $48,000 ($5,000 in Cost of Goods Sold and $43,000 in Selling, General and Administrative expenses) in 2009, $41,000 ($5,000related to these and previously issued grants.

There were no Restricted Stock Unit awards in Cost of Goods Sold2010 and $36,000 in Selling, General and Administrative expenses) in 2008 and $0 in 2007.


2009.

A summary of the Company’s non-vested restricted stock unit awards shares is as follows:


 # of Units 
Weighted Average
Grant Date
Fair Value
 
Outstanding as of January 1, 200812,000 $4.00 
Granted                                           23,500  $3.63 
Vested                                               (4,000)  $4.00 
Forfeited/Expired                                                $ 
Outstanding as of December 31, 200831,500  $3.72 
Granted                                                 $ 
Vested                                               (13,504)  $3.79 
Forfeited/Expired                                               $ 
Outstanding as of December 31, 2009                                           17,996  $3.68 

  # of Units  Weighted Average
Grant Date
Fair Value
$
 
       
Outstanding as of January 1, 2009  31,500   3.72 
Granted      
Vested  (13,504)  3.79 
Forfeited/Expired      
Outstanding as of December 31, 2009  17,996   3.68 
Granted      
Vested  (6,998)  3.59 
Forfeited/Expired  (4,000)  4.00 
Outstanding as of December 31, 20010  6,998   3.59 
Granted  15,000   .97 
Vested  (6,998)  3.59 
Forfeited/Expired      
Outstanding as of December 31, 2011  15,000   .97 

The total fair value of restricted stock units which vested during 2011, 2010 and 2009 was $20,774$6,900, $8,500 and $20,800, respectively, as of the vesting date.

40

11.Net Income (Loss) per Share

11.Net (Loss) Income per Share

The Company computes and presents net (loss)Basic income per common share in accordance with FASB ASC Topic 260, “Earnings per Share”.  Basic (loss) income per common share is computed by dividing net income (loss) income by the weighted average number of common shares outstanding. Diluted income (loss) income per common share is computed by dividing net income (loss) income by the weighted average number of common shares and common stock equivalents outstanding, calculated on the treasury stock method for options, stock grants and warrants using the average market prices during the period, including potential common shares issuable upon conversion of outstanding convertible notes, except if the effect on the per share amounts is anti-dilutive.For the year ended December 31, 2011, a total of 94,778 common share equivalents were assumed to be outstanding at the end of the year. A total of 2,500,000 anti-dilutive common shares issuable upon conversion of outstanding convertible notes have been excluded from the diluted computation because their effect is anti-dilutive.

For the year ended December 31, 2010 and 2009, all common equivalent shares outstanding have been excluded from the diluted computation because their effect is anti-dilutive.

This included a weighted average of 2,500,000 anti-dilutive common shares issuable upon conversion of outstanding convertible notes.notes and 1,125,000 anti-dilutive common shares issuable on conversion of accrued interest. The weighted average number of outstanding anti-dilutive warrants excluded from the computation of diluted net income per common share year ended December 31, 20092010 was 193,5002,718,750 and the weighted average number of outstanding anti-dilutive common stock options was 259,987.798,476. In addition, a total weighted average of 14,7896,998 shares of non-vested restricted stock with a grant date fair value in excess of the average market price of the common shares during the year was excluded from the computation because their effect is anti-dilutive.

A reconciliation of the shares used in the calculation of basic and diluted earnings per common share is as follows:


  Years ended December 31, 
  2009  2008  2007 
Numerators         
          
Net (loss) income applicable to common shareholders - basic $(2,799,992) $1,098,421  $1,641,914 
Interest on Convertible Debt     150,000   188,096 
Net (loss) income applicable to common shareholders - diluted $(2,799,992) $1,248,421  $1,830,010 
             
Denominators            
             
Weighed average shares outstanding-Basic  11,331,258   10,902,061   8,609,822 
Convertible Debt     2,500,000   3,102,740 
Warrants     1,615,417   1,585,206 
Stock options     594,972   479,346 
Restricted stock units     6,854    
Weighted average shares outstanding - diluted  11,331,258   15,619,304   13,777,114 
             
Net income per common share – basic $(0.25) $0.10  $0.19 
Net income per common share — diluted $(0.25) $0.08  $0.13 
12.           Work Force Reduction
In the first quarter of 2009, the Company reduced its combined work-force by approximately 23%, in order to eliminate costs and align it’s workforce with its current business requirements while ensuring the Company would continue to meet its customers’ needs.  The reductions affected both the Company’s Northvale, NJ and the Sarasota, FL operations. Annualized savings from the reductions are expected to be approximately $1.1 million.  Severance payments expensed in the first quarter of the year but paid in the first and second quarters of the year totaled approximately $140,000.
13.           Commitments

  Years ended December 31, 
  2011  2010  2009 
Numerators            
             
Net income (loss) applicable to common shareholders - basic $164,786  $(733,813) $(2,799,992)
Interest on Convertible Debt         
Net income (loss) applicable to common shareholders - diluted $164,786  $(733,813) $(2,799,922)
             
Denominators            
             
Weighted average shares outstanding-basic  11,658,891   11,522,297   11,331,258 
Stock options  83,843       
Restricted stock units  10,935       
Weighted average shares outstanding – diluted  11,753,669   11,522,297   11,331,258 

a.  Lease commitments12.Commitments

a.Lease commitments

The Company occupies approximately 42,000 square feet of space located at 181 Legrand Avenue, Northvale, New Jersey pursuant to a net lease. Under the terms of the lease, the Company is obligated for all real estate taxes, maintenance and operating costs of the facility. On November 1, 2008,2011, the Company negotiated a change to the rate on its Northvale lease and extended the term until October 31, 2013. The Company also has the option of renewing the lease was renewed for a twoone year, term to October 31, 2010, at substantially the same terms.  The Company has options to renew the Northvale lease for two additional two yearfixed terms, running through October 31, 2012, with fixed terms.

2014.

The Company’s wholly-owned subsidiary, MRC Precision Metal Optics, subsidiaryInc., occupies approximately 25,000 square feet of space located at 6405 Parkland Drive, Sarasota, FL pursuant to a net lease originally expiring on August 31, 2006. Under the terms of the lease, the Company is obligated for all real estate taxes, maintenance and operating costs of the facility. During 2006, MRC Opticsthe Company negotiated terms for the renewal of the lease until August 31, 2008.  In2008 and in 2008, the Company elected to extend the lease until August 31, 2010. In August 2010, and has the optionCompany negotiated terms for the renewal of three additional two year renewal periods throughthe lease until August 31, 2016.

41

2013.

The total rent for these leases was approximately $519,000, $569,000 and $582,000 $588,000in 2011, 2010 and $570,000 in 2009, 2008 and 2007, respectively.

Future minimum annual rentals which cover the remaining lease terms, excluding uncommitted option renewal periods are $451,000 for 2010.


as follows:

Year ending December 31: 
2012  $440,000 
2013   393,000 
2014   253,000 
   $1,086,000 

b.  b.Retirement plans

The Company maintains a 401(k) savings plan (the “Plan”) for all eligible employees (as defined in the plan). The 401(k) plan allows employees to contribute up to 20% of their compensation on a salary reduction, pre-tax basis up to the statutory limitation. The 401(k) plan also provides that the Company, at the discretion of the Board of Directors, may match employee contributions based on a pre-determined formula.

In 2011, the Company matched employee contributions of $151,775 in the form of 152,460 shares of the Company’s common stock, which were issued to the Plan in March 2012. In 2010, the Company matched employee contributions of $129,998 in the form of 124,669 shares of the Company’s common stock, which were issued to the Plan in March 2011. In 2009, the Company matched employee contributions of $154,524$154,535 in the form of 103,403 shares of the Company’s common stock, which were issued to the Plan in March 2010.  In 2008, the Company matched employee contributions in the amount of $179,068 contributed in the form of 66,469 shares of the Company’s common stock, distributed in February 2009.  The Company contributed $160,181 in the form of 75,907 shares of the Company’s common stock in March 2008 for the 2007 fiscal year. The Company records the distribution of the common shares in the Consolidated Statement of Shareholders’ Equity as of the date of distribution to the 401(k) plan administrator.

38
14.           Product Sales, Foreign Sales and Sales to Major Customers

13.Product Sales, Foreign Sales and Sales to Major Customers

The following table summarizes the Company’s productnet sales by product categories during the past three years:


Year Ended December 31, 2009  2008  2007 
Category Sales  %  Sales  %  Sales  % 
Optical Components $10,350,000   94  $14,750,000   90  $13,410,000   89 
Laser Accessories  701,000   6   1,551,000   10   1,690,000   11 
TOTAL $11,051,000   100  $16,301,000   100  $15,100,000   100 

Year Ended December 31, 2011  2010  2009 
Category Net Sales  %  Net Sales  %  Net Sales  % 
Optical Components $11,812,000   90  $10,115,000   92  $10,350,000   94 
Laser System Devices and Instrumentation  1,365,000   10   939,000   8   701,000   6 
Total $13,177,000   100  $11,054,000   100  $11,051,000   100 

The Company’s export sales, which are primarily to customers in countries within Europe, the Near EastAsia and Japan, amounted to approximately 7.2%22.8%, 5.2%14.9%, and 9.5%12.5% of product sales in 2011, 2010 and 2009, 2008 and 2007, respectively.

respectively

The Company had sales to three major domestic customers which accounted for 17.7%20.9%, 15.4% and 13.8%, and 9.8%10.8% of sales.  Each customersales in 2011. The largest is an international customer that is in the process control and metrology industry. Both of the other major customers are electro-optical systems divisiondivisions of a major U.S. defense corporationindustry corporations who manufactures systems for U.S. and allied foreign governments. In 2008,2010, the same three customers represented 8.7%10.1%, 21.6%10.3% and 5.9%15.3% of sales, respectively.

In 2009, the same three customers represented 5.5%, 4.7% and 17.7% of sales, respectively.

During the past three years, sales to the Company’s top five customers represented approximately 51.6%58.1%, 58.8%54.3% and 56.9%55.3% of sales, respectively. Given the concentration of sales within a small number of customers, the loss of any of these customers would have a significant negative impact on the Company and its business units.

15.Shareholders’ Equity

a.  14.Shareholders’ Equity

a.Common shares reserved at December 31, 2009,2011, are as follows:

2010 Equity compensation plan4,000,000
2000 Equity compensation plan  6,000,000669,676 
Subordinated convertible notes  2,500,000 
Warrants issuable on conversion of Subordinated convertible notes  1,875,000 
Warrants outstanding  60,000
Accrued interest convertible to common shares at $1.00 per share975,0009,044,676 

b.  Preferred stockb.Warrants
The Company has authorized 1,000,000 shares of preferred stock, no par value, which the Board of Directors has the authority to issue from time to time in a series.  The Board of Directors also has the authority to fix, before the issuance of each series, the number of shares in each series and the designation, preferences, rights and limitations of each series.

The Company had no shares of preferred stock issued and outstanding warrants as of December 31, 2009 or 2008.

42

In 2007, the Series A preferred stock consisting of 500 shares at a stated value of $1,000 per share2011 and convertible into common shares at the rate of $1.00 per share was converted into 500,000 common shares of the Company’s stock in April 2007.
A total of 2,032 shares of the Series B preferred stock consisting of 2,082 shares at a stated value of $1,000 per share and convertible into common shares at the rate of $2.50 per share were converted in October and November of 2007.  One holder of the remaining 50 shares of Series B preferred stock elected to redeem its shares for a cash payment of $50,000 and an accrued stock dividend of 1,332 common shares of the Company.
There were no common stock dividends, either declared or paid, for the year ended December 31, 2009 or 2008.  For the years ended December 31, 2007, the Company paid a common stock dividend on preferred stock of 134,612 shares equal to $238,167 based on the closing market price of the common shares on the issue date.
c.           Warrants
2010. As of December 31, 2009, the Company hashad 60,000 outstanding warrants with an exercise price of $1.35 and a fair value of $1.31 which expireexpired in May 2010. During the year ended December 31, 2009, a total of 50,000 warrants were exercised with a fair value of $1.29 and an exercise price of $1.35 each or $67,500, in total. A total of 893,790 warrants with an exercise price of $1.35 and fair value of $1.29 expired during the year.
16.Fair Value of Financial Instruments
in 2009.

15.Fair Value of Financial Instruments

The methods and assumptions used to estimate the fair value of the following classes of financial instruments were:

Current Assets and Current Liabilities: The carrying amount of cash, certificates of deposits, current receivables and payables and certain other short-term financial instruments approximate their fair value as of December 31, 20092011 due to their short-term maturities.

Long-Term Debt: The fair value of the Company’s long-term debt, including the current portion, for notes payable and subordinated convertible debentures, was estimated using a discounted cash flow analysis, based on the Company’s assumed incremental borrowing rates for similar types of borrowing arrangements. The carrying amount of variable and fixed rate debt at December 31, 20092011 in the amount of $2,854,000$2,835,000 approximates fair value.

17.Quarterly Data (Unaudited)

16.Quarterly Data (Unaudited)

Summary quarterly results were as follows:

Year 2011 First  Second  Third  Fourth 
             
Net sales $3,241,434  $3,221,234  $3,328,761  $3,385,765 
Gross profit  872,537   784,060   907,905   997,817 
Net income (loss)  34,729   (95,750)  83,731   142,036 
Net income (loss) per share - Basic  0.00   (0.01)  0.01   0.01 
Net income (loss) per share – Diluted  0.00   (0.01)  0.01   0.01 

Year 2010 First  Second  Third  Fourth 
             
Net sales $2,808,046  $2,164,491  $2,478,581  $3,603,060 
Gross profit  540,494   255,712   494,678   1,218,141 
Net loss  (274,469)  (648,898)  (281,755)  471,309 
Net loss per share - Basic  (0.02)  (0.06)  (0.02)  0.04 
Net loss per share - Diluted  (0.02)  (0.06)  (0.02)  0.04 

Year 2009 First  Second  Third  Fourth 
             
Net sales $2,815,097  $2,620,437  $2,664,963  $2,950,630 
Gross profit  381,687   419,098   606,530   747,273 
Net loss  (314,409)  (336,998)  (2,122,330)  (26,225)
Net loss per share - Basic  (0.03)  (0.03)  (0.19)  (0.00)
Net loss per share - Diluted  (0.03)  (0.03)  (0.19)  (0.00)

40

Year 2009 First  Second  Third  Fourth 
             
Net sales $2,815,097  $2,620,437  $2,664,963  $2,950,630 
Gross profit  381,687   419,098   606,530   747,273 
Net loss  (314,409)  (336,998)  (2,122,330)  (26,255)
Net loss per share - Basic  (0.03)  (0.03)  (0.19)  (0.00)
Net loss per share - Diluted  (0.03)  (0.03)  (0.19)  (0.00)


Year 2008 First  Second  Third  Fourth 
             
Net sales $4,164,248  $4,007,412  $3,802,935  $4,326,614 
Gross profit  1,501,593   1,219,202   1,065,424   1,028,370 
Net income  491,200   294,017   169,120   144,084 
Net income per share - Basic  0.05   0.03   0.02   0.01 
Net income per share - Diluted  0.03   0.02   0.01   0.01 

Year 2007 First  Second  Third  Fourth 
             
Net sales $3,540,874  $3,678,796  $3,837,660  $4,042,548 
Gross profit  1,381,500   1,393,238   815,825   1,368,266 
Net income  434,860   396,488   797,413   251,320 
Net income per share - Basic  0.06   0.02   0.09   0.03 
Net income per share – Diluted  0.04   0.02   0.06   0.02 

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

  Balance at
Beginning
of Period
  Charged
(Credited)
to Expenses
  Additions
(Deductions) 
to Other 
Accounts
  Deductions  Balance
at End of
Period
 
Allowance for Doubtful Accounts                    
Year ended December 31, 2011 $15,000           $15,000 
Year ended December 31, 2010 $15,000           $15,000 
Year ended December 31, 2009 $15,000           $15,000 
                     
Valuation Allowance for Deferred Tax Assets                    
Year ended December 31, 2011 $2,379,000      73,000     $2,452,000 
Year ended December 31, 2010 $2,108,000      271,000     $2,379,000 
Year ended December 31, 2009 $1,733,000      375,000     $2,108,000 

41
  
Balance at
Beginning
of Period
  
Charged
(Credited)
to Expenses
  
Additions (Deductions)
to Other
Accounts
  Deductions  
Balance
at End of
Period
 
                
Allowance for Doubtful Accounts               
Year ended December 31, 2009 $15,000           $15,000 
Year ended December 31, 2008 $15,000           $15,000 
Year Ended December 31, 2007 $15,000           $15,000 
                     
Valuation Allowance for Deferred Tax Assets              
Year ended December 31, 2009 $1,733,000      716,000     $2,449,000 
Year ended December 31, 2008 $2,041,000   (408,000)  100,000     $1,733,000 
Year Ended December 31, 2007 $3,065,000      (1,024,000    $2,041,000 

44